Gene Symbol | Gene ID | Gene Info |
---|---|---|
TFAP2C
|
ENSG00000087510.5 | transcription factor AP-2 gamma |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr20_55202198_55202349 | TFAP2C | 2085 | 0.272964 | 0.82 | 6.2e-03 | Click! |
chr20_55203708_55203859 | TFAP2C | 575 | 0.717531 | 0.81 | 7.5e-03 | Click! |
chr20_55209051_55209202 | TFAP2C | 3188 | 0.210408 | 0.79 | 1.2e-02 | Click! |
chr20_55212096_55212296 | TFAP2C | 6258 | 0.169166 | 0.78 | 1.3e-02 | Click! |
chr20_55209986_55210137 | TFAP2C | 4123 | 0.189040 | 0.76 | 1.7e-02 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr11_66102741_66104078 | 2.69 |
RIN1 |
Ras and Rab interactor 1 |
468 |
0.53 |
chr19_4472643_4473577 | 2.38 |
HDGFRP2 |
Hepatoma-derived growth factor-related protein 2 |
807 |
0.39 |
chr4_55096373_55096991 | 2.32 |
PDGFRA |
platelet-derived growth factor receptor, alpha polypeptide |
193 |
0.97 |
chr7_21582433_21583565 | 2.09 |
DNAH11 |
dynein, axonemal, heavy chain 11 |
166 |
0.97 |
chr22_37914692_37915408 | 2.04 |
CARD10 |
caspase recruitment domain family, member 10 |
197 |
0.92 |
chr6_117086060_117086951 | 2.02 |
FAM162B |
family with sequence similarity 162, member B |
381 |
0.87 |
chr6_54711000_54712080 | 1.98 |
FAM83B |
family with sequence similarity 83, member B |
29 |
0.98 |
chr4_75718841_75720131 | 1.94 |
BTC |
betacellulin |
410 |
0.91 |
chr2_242497891_242499073 | 1.86 |
BOK-AS1 |
BOK antisense RNA 1 |
90 |
0.79 |
chr16_2517636_2518674 | 1.84 |
RP11-715J22.2 |
|
59 |
0.92 |
chr3_126702505_126703684 | 1.83 |
PLXNA1 |
plexin A1 |
4343 |
0.34 |
chr16_73082076_73082698 | 1.82 |
ZFHX3 |
zinc finger homeobox 3 |
113 |
0.97 |
chr2_24232585_24233394 | 1.80 |
MFSD2B |
major facilitator superfamily domain containing 2B |
22 |
0.97 |
chr13_114541163_114541465 | 1.79 |
GAS6 |
growth arrest-specific 6 |
2297 |
0.34 |
chr1_14924992_14926197 | 1.77 |
KAZN |
kazrin, periplakin interacting protein |
381 |
0.93 |
chr2_206546644_206547002 | 1.73 |
NRP2 |
neuropilin 2 |
401 |
0.91 |
chr19_49864989_49865626 | 1.70 |
DKKL1 |
dickkopf-like 1 |
267 |
0.51 |
chr6_159239962_159240825 | 1.68 |
EZR |
ezrin |
51 |
0.96 |
chr1_231297648_231298418 | 1.67 |
TRIM67 |
tripartite motif containing 67 |
175 |
0.95 |
chr11_65414495_65414986 | 1.60 |
ENSG00000265874 |
. |
1923 |
0.15 |
chr4_119273101_119273655 | 1.59 |
PRSS12 |
protease, serine, 12 (neurotrypsin, motopsin) |
780 |
0.76 |
chr3_44036429_44037293 | 1.59 |
ENSG00000252980 |
. |
75718 |
0.11 |
chr2_160918347_160919586 | 1.58 |
PLA2R1 |
phospholipase A2 receptor 1, 180kDa |
155 |
0.98 |
chr14_105332332_105332761 | 1.54 |
CEP170B |
centrosomal protein 170B |
892 |
0.57 |
chr19_46916092_46916684 | 1.54 |
CCDC8 |
coiled-coil domain containing 8 |
453 |
0.75 |
chr16_54970178_54971110 | 1.53 |
IRX5 |
iroquois homeobox 5 |
4660 |
0.36 |
chr20_55204347_55205219 | 1.51 |
TFAP2C |
transcription factor AP-2 gamma (activating enhancer binding protein 2 gamma) |
425 |
0.81 |
chrX_39548256_39548819 | 1.51 |
ENSG00000263730 |
. |
28067 |
0.24 |
chr3_167812746_167813857 | 1.48 |
GOLIM4 |
golgi integral membrane protein 4 |
169 |
0.97 |
chr8_22027174_22027581 | 1.47 |
BMP1 |
bone morphogenetic protein 1 |
4577 |
0.12 |
chr2_241949003_241950045 | 1.46 |
AC093585.6 |
|
637 |
0.62 |
chr12_6493326_6493955 | 1.44 |
LTBR |
lymphotoxin beta receptor (TNFR superfamily, member 3) |
221 |
0.89 |
chr9_35489468_35490886 | 1.43 |
RUSC2 |
RUN and SH3 domain containing 2 |
53 |
0.97 |
chr15_96897591_96898313 | 1.43 |
AC087477.1 |
Uncharacterized protein |
6535 |
0.18 |
chr17_21279729_21280949 | 1.42 |
KCNJ12 |
potassium inwardly-rectifying channel, subfamily J, member 12 |
830 |
0.69 |
chr1_201436884_201437966 | 1.42 |
PHLDA3 |
pleckstrin homology-like domain, family A, member 3 |
887 |
0.55 |
chr9_33523659_33524999 | 1.41 |
ANKRD18B |
ankyrin repeat domain 18B |
63 |
0.97 |
chr21_47401799_47402727 | 1.41 |
COL6A1 |
collagen, type VI, alpha 1 |
612 |
0.75 |
chr20_4129930_4130735 | 1.41 |
SMOX |
spermine oxidase |
750 |
0.71 |
chr7_100464814_100466140 | 1.40 |
TRIP6 |
thyroid hormone receptor interactor 6 |
717 |
0.47 |
chr7_51383611_51384133 | 1.39 |
COBL |
cordon-bleu WH2 repeat protein |
296 |
0.95 |
chr1_15479287_15480043 | 1.39 |
TMEM51 |
transmembrane protein 51 |
564 |
0.8 |
chr6_19838575_19839711 | 1.37 |
RP1-167F1.2 |
|
168 |
0.95 |
chr16_1664599_1665551 | 1.35 |
CRAMP1L |
Crm, cramped-like (Drosophila) |
434 |
0.69 |
chr16_54318004_54318459 | 1.34 |
IRX3 |
iroquois homeobox 3 |
1536 |
0.47 |
chr19_45754620_45755932 | 1.33 |
MARK4 |
MAP/microtubule affinity-regulating kinase 4 |
726 |
0.57 |
chr3_69788614_69789040 | 1.33 |
MITF |
microphthalmia-associated transcription factor |
205 |
0.96 |
chr17_79317268_79317735 | 1.32 |
TMEM105 |
transmembrane protein 105 |
13027 |
0.13 |
chr21_38071900_38072434 | 1.32 |
SIM2 |
single-minded family bHLH transcription factor 2 |
176 |
0.94 |
chr11_65158052_65158759 | 1.31 |
FRMD8 |
FERM domain containing 8 |
4006 |
0.13 |
chr21_40984409_40984913 | 1.31 |
C21orf88 |
chromosome 21 open reading frame 88 |
87 |
0.97 |
chr16_2210764_2211128 | 1.30 |
TRAF7 |
TNF receptor-associated factor 7, E3 ubiquitin protein ligase |
2597 |
0.09 |
chr16_54321004_54321411 | 1.28 |
IRX3 |
iroquois homeobox 3 |
532 |
0.83 |
chr19_55684291_55685412 | 1.28 |
SYT5 |
synaptotagmin V |
1083 |
0.28 |
chr19_13107353_13108160 | 1.28 |
NFIX |
nuclear factor I/X (CCAAT-binding transcription factor) |
1104 |
0.3 |
chr4_682374_683342 | 1.28 |
MFSD7 |
major facilitator superfamily domain containing 7 |
74 |
0.94 |
chr4_150999769_151000790 | 1.27 |
DCLK2 |
doublecortin-like kinase 2 |
99 |
0.98 |
chr2_27301899_27302732 | 1.27 |
EMILIN1 |
elastin microfibril interfacer 1 |
880 |
0.32 |
chr22_34315378_34316336 | 1.26 |
LARGE |
like-glycosyltransferase |
469 |
0.83 |
chr6_123110376_123110857 | 1.25 |
SMPDL3A |
sphingomyelin phosphodiesterase, acid-like 3A |
145 |
0.96 |
chr2_159825200_159826543 | 1.25 |
TANC1 |
tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1 |
688 |
0.73 |
chr3_52016673_52017699 | 1.25 |
ABHD14B |
abhydrolase domain containing 14B |
239 |
0.49 |
chr11_61684550_61685041 | 1.24 |
RAB3IL1 |
RAB3A interacting protein (rabin3)-like 1 |
202 |
0.91 |
chr17_34611752_34612896 | 1.24 |
CCL3L1 |
chemokine (C-C motif) ligand 3-like 1 |
13395 |
0.14 |
chr11_94473290_94474384 | 1.24 |
RP11-867G2.8 |
|
316 |
0.92 |
chr3_120004025_120004467 | 1.23 |
GPR156 |
G protein-coupled receptor 156 |
305 |
0.92 |
chr7_150779695_150780926 | 1.23 |
TMUB1 |
transmembrane and ubiquitin-like domain containing 1 |
9 |
0.94 |
chr11_70244216_70245100 | 1.23 |
CTTN |
cortactin |
11 |
0.53 |
chr6_78172796_78173983 | 1.23 |
HTR1B |
5-hydroxytryptamine (serotonin) receptor 1B, G protein-coupled |
101 |
0.99 |
chr10_35102956_35103650 | 1.23 |
PARD3 |
par-3 family cell polarity regulator |
946 |
0.5 |
chr20_44098779_44099661 | 1.23 |
WFDC2 |
WAP four-disulfide core domain 2 |
824 |
0.44 |
chr3_48631948_48632718 | 1.23 |
COL7A1 |
collagen, type VII, alpha 1 |
260 |
0.83 |
chr2_133427269_133427458 | 1.23 |
LYPD1 |
LY6/PLAUR domain containing 1 |
415 |
0.87 |
chr5_134366245_134366951 | 1.21 |
PITX1 |
paired-like homeodomain 1 |
2227 |
0.27 |
chrX_20134537_20135074 | 1.21 |
MAP7D2 |
MAP7 domain containing 2 |
55 |
0.97 |
chr12_53443889_53444561 | 1.20 |
TENC1 |
tensin like C1 domain containing phosphatase (tensin 2) |
255 |
0.86 |
chr1_180881914_180882730 | 1.20 |
KIAA1614 |
KIAA1614 |
3 |
0.98 |
chr11_33398103_33398382 | 1.19 |
ENSG00000223134 |
. |
22231 |
0.24 |
chr17_74581180_74582274 | 1.19 |
ST6GALNAC2 |
ST6 (alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1,3)-N-acetylgalactosaminide alpha-2,6-sialyltransferase 2 |
483 |
0.62 |
chr5_122425011_122425806 | 1.18 |
AC106786.1 |
|
418 |
0.57 |
chr19_1566819_1567637 | 1.18 |
MEX3D |
mex-3 RNA binding family member D |
301 |
0.76 |
chr9_71939475_71940274 | 1.17 |
FAM189A2 |
family with sequence similarity 189, member A2 |
386 |
0.91 |
chr11_118478413_118479735 | 1.17 |
PHLDB1 |
pleckstrin homology-like domain, family B, member 1 |
716 |
0.54 |
chr1_16343782_16344178 | 1.16 |
HSPB7 |
heat shock 27kDa protein family, member 7 (cardiovascular) |
340 |
0.8 |
chr3_64430574_64431219 | 1.15 |
PRICKLE2 |
prickle homolog 2 (Drosophila) |
162 |
0.97 |
chr11_7273374_7273682 | 1.15 |
SYT9 |
synaptotagmin IX |
347 |
0.9 |
chr22_19973614_19974692 | 1.15 |
ARVCF |
armadillo repeat gene deleted in velocardiofacial syndrome |
463 |
0.71 |
chr12_54391177_54391923 | 1.14 |
HOXC-AS2 |
HOXC cluster antisense RNA 2 |
981 |
0.22 |
chr22_45898941_45899504 | 1.14 |
FBLN1 |
fibulin 1 |
296 |
0.92 |
chr7_29603979_29604650 | 1.14 |
PRR15 |
proline rich 15 |
752 |
0.51 |
chr19_17953136_17953665 | 1.13 |
JAK3 |
Janus kinase 3 |
1856 |
0.22 |
chr12_125002064_125002257 | 1.13 |
NCOR2 |
nuclear receptor corepressor 2 |
680 |
0.82 |
chr10_79396627_79397649 | 1.13 |
KCNMA1 |
potassium large conductance calcium-activated channel, subfamily M, alpha member 1 |
67 |
0.98 |
chrX_69674453_69675874 | 1.12 |
DLG3 |
discs, large homolog 3 (Drosophila) |
217 |
0.75 |
chr7_45928070_45928578 | 1.12 |
IGFBP1 |
insulin-like growth factor binding protein 1 |
228 |
0.93 |
chrX_50556610_50557434 | 1.12 |
SHROOM4 |
shroom family member 4 |
22 |
0.99 |
chr14_105886805_105887920 | 1.12 |
MTA1 |
metastasis associated 1 |
1087 |
0.31 |
chr13_40176285_40177298 | 1.12 |
LHFP |
lipoma HMGIC fusion partner |
517 |
0.82 |
chr9_140500205_140501463 | 1.12 |
ARRDC1 |
arrestin domain containing 1 |
679 |
0.56 |
chr10_15411519_15412658 | 1.11 |
FAM171A1 |
family with sequence similarity 171, member A1 |
970 |
0.7 |
chr2_14775112_14775752 | 1.11 |
AC011897.1 |
Uncharacterized protein |
217 |
0.95 |
chr10_29010987_29011704 | 1.11 |
ENSG00000201001 |
. |
38387 |
0.14 |
chr9_124360553_124361088 | 1.11 |
RP11-524G24.2 |
|
22327 |
0.18 |
chr18_6729547_6730123 | 1.10 |
ARHGAP28 |
Rho GTPase activating protein 28 |
14 |
0.5 |
chr2_38303069_38303895 | 1.10 |
CYP1B1-AS1 |
CYP1B1 antisense RNA 1 |
156 |
0.5 |
chr2_219858277_219858732 | 1.09 |
CRYBA2 |
crystallin, beta A2 |
361 |
0.74 |
chr9_109622995_109623671 | 1.09 |
ZNF462 |
zinc finger protein 462 |
2045 |
0.37 |
chr9_35689462_35689834 | 1.09 |
TPM2 |
tropomyosin 2 (beta) |
252 |
0.8 |
chr10_112835970_112837137 | 1.09 |
ADRA2A |
adrenoceptor alpha 2A |
237 |
0.95 |
chr6_150246697_150247451 | 1.09 |
RAET1G |
retinoic acid early transcript 1G |
2817 |
0.17 |
chr1_110693132_110693795 | 1.08 |
SLC6A17 |
solute carrier family 6 (neutral amino acid transporter), member 17 |
355 |
0.81 |
chr22_41633466_41634617 | 1.08 |
CHADL |
chondroadherin-like |
1584 |
0.26 |
chr14_25519423_25519778 | 1.08 |
STXBP6 |
syntaxin binding protein 6 (amisyn) |
97 |
0.98 |
chr14_73706275_73706778 | 1.08 |
PAPLN |
papilin, proteoglycan-like sulfated glycoprotein |
193 |
0.92 |
chr1_16085392_16086186 | 1.07 |
FBLIM1 |
filamin binding LIM protein 1 |
497 |
0.68 |
chr5_78985270_78986298 | 1.07 |
CMYA5 |
cardiomyopathy associated 5 |
84 |
0.98 |
chr6_1619961_1620659 | 1.07 |
FOXC1 |
forkhead box C1 |
9629 |
0.3 |
chr9_140093629_140094566 | 1.07 |
TPRN |
taperin |
460 |
0.53 |
chr2_236403404_236403896 | 1.06 |
AGAP1 |
ArfGAP with GTPase domain, ankyrin repeat and PH domain 1 |
899 |
0.65 |
chr15_91500342_91500803 | 1.06 |
RCCD1 |
RCC1 domain containing 1 |
1546 |
0.18 |
chr7_556342_556585 | 1.06 |
PDGFA |
platelet-derived growth factor alpha polypeptide |
1682 |
0.39 |
chr3_159481083_159481637 | 1.06 |
IQCJ-SCHIP1 |
IQCJ-SCHIP1 readthrough |
142 |
0.96 |
chr5_2752285_2752739 | 1.06 |
C5orf38 |
chromosome 5 open reading frame 38 |
133 |
0.91 |
chr2_232276665_232277472 | 1.06 |
B3GNT7 |
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7 |
16814 |
0.12 |
chr3_55522456_55523178 | 1.06 |
WNT5A-AS1 |
WNT5A antisense RNA 1 |
1090 |
0.43 |
chr5_131562588_131563831 | 1.06 |
P4HA2 |
prolyl 4-hydroxylase, alpha polypeptide II |
138 |
0.96 |
chr8_22224818_22225894 | 1.05 |
SLC39A14 |
solute carrier family 39 (zinc transporter), member 14 |
305 |
0.9 |
chr2_239924798_239924986 | 1.05 |
ENSG00000211566 |
. |
30186 |
0.1 |
chr2_47596926_47597240 | 1.05 |
EPCAM |
epithelial cell adhesion molecule |
449 |
0.79 |
chr2_110872434_110873339 | 1.04 |
MALL |
mal, T-cell differentiation protein-like |
713 |
0.63 |
chr11_111169649_111170452 | 1.04 |
COLCA2 |
colorectal cancer associated 2 |
74 |
0.88 |
chr12_52701821_52702383 | 1.03 |
RP11-845M18.6 |
|
53 |
0.94 |
chr8_145012479_145013719 | 1.03 |
PLEC |
plectin |
659 |
0.56 |
chr5_1110808_1112337 | 1.03 |
SLC12A7 |
solute carrier family 12 (potassium/chloride transporter), member 7 |
578 |
0.75 |
chr22_23863444_23864162 | 1.03 |
AP000345.2 |
|
45448 |
0.12 |
chr6_44264722_44265466 | 1.03 |
TCTE1 |
t-complex-associated-testis-expressed 1 |
331 |
0.81 |
chr5_112823124_112823740 | 1.02 |
MCC |
mutated in colorectal cancers |
1095 |
0.49 |
chr19_2049519_2050886 | 1.01 |
MKNK2 |
MAP kinase interacting serine/threonine kinase 2 |
650 |
0.55 |
chr1_39980649_39981517 | 1.01 |
RP11-69E11.4 |
|
9465 |
0.14 |
chr11_44338057_44338887 | 1.01 |
ALX4 |
ALX homeobox 4 |
6756 |
0.31 |
chr2_121103939_121104858 | 1.01 |
INHBB |
inhibin, beta B |
679 |
0.78 |
chr7_1709889_1710442 | 1.01 |
ELFN1 |
extracellular leucine-rich repeat and fibronectin type III domain containing 1 |
17590 |
0.18 |
chr17_64187141_64188685 | 1.00 |
CEP112 |
centrosomal protein 112kDa |
60 |
0.98 |
chr9_133320290_133320711 | 1.00 |
ASS1 |
argininosuccinate synthase 1 |
121 |
0.96 |
chr8_12808711_12809195 | 0.99 |
KIAA1456 |
KIAA1456 |
112 |
0.98 |
chr13_37005266_37006411 | 0.99 |
CCNA1 |
cyclin A1 |
129 |
0.97 |
chr5_175625925_175626539 | 0.99 |
SIMC1 |
SUMO-interacting motifs containing 1 |
39133 |
0.15 |
chr22_37957123_37957770 | 0.99 |
CDC42EP1 |
CDC42 effector protein (Rho GTPase binding) 1 |
959 |
0.43 |
chr22_42306303_42307311 | 0.99 |
SHISA8 |
shisa family member 8 |
3763 |
0.12 |
chr11_94501626_94502525 | 0.98 |
AMOTL1 |
angiomotin like 1 |
538 |
0.82 |
chr1_170633420_170634117 | 0.98 |
PRRX1 |
paired related homeobox 1 |
690 |
0.8 |
chr19_3606102_3607092 | 0.98 |
TBXA2R |
thromboxane A2 receptor |
61 |
0.89 |
chr5_113697124_113698006 | 0.98 |
KCNN2 |
potassium intermediate/small conductance calcium-activated channel, subfamily N, member 2 |
451 |
0.9 |
chr11_8615266_8616201 | 0.97 |
STK33 |
serine/threonine kinase 33 |
26 |
0.97 |
chr1_33358710_33359190 | 0.97 |
HPCA |
hippocalcin |
6914 |
0.13 |
chr1_234630809_234631231 | 0.97 |
TARBP1 |
TAR (HIV-1) RNA binding protein 1 |
16171 |
0.21 |
chr16_51184635_51185066 | 0.97 |
SALL1 |
spalt-like transcription factor 1 |
302 |
0.89 |
chr4_186456384_186456582 | 0.97 |
PDLIM3 |
PDZ and LIM domain 3 |
173 |
0.95 |
chr11_118492062_118492969 | 0.97 |
PHLDB1 |
pleckstrin homology-like domain, family B, member 1 |
14157 |
0.11 |
chr15_83875578_83876391 | 0.96 |
HDGFRP3 |
Hepatoma-derived growth factor-related protein 3 |
786 |
0.64 |
chr5_141703297_141704624 | 0.96 |
SPRY4 |
sprouty homolog 4 (Drosophila) |
213 |
0.88 |
chr5_68710635_68711790 | 0.96 |
MARVELD2 |
MARVEL domain containing 2 |
3 |
0.97 |
chrX_38079311_38080259 | 0.96 |
SRPX |
sushi-repeat containing protein, X-linked |
367 |
0.75 |
chr22_38484733_38485185 | 0.95 |
BAIAP2L2 |
BAI1-associated protein 2-like 2 |
14 |
0.96 |
chr13_27131903_27132772 | 0.95 |
WASF3 |
WAS protein family, member 3 |
450 |
0.89 |
chr15_40626168_40626616 | 0.95 |
ENSG00000252714 |
. |
2543 |
0.12 |
chr2_131185158_131185614 | 0.95 |
FAR2P2 |
fatty acyl CoA reductase 2 pseudogene 2 |
3550 |
0.18 |
chr16_4366907_4367444 | 0.95 |
GLIS2 |
GLIS family zinc finger 2 |
2413 |
0.21 |
chr3_44037532_44037973 | 0.94 |
ENSG00000252980 |
. |
74827 |
0.11 |
chr16_4986136_4987107 | 0.94 |
PPL |
periplakin |
444 |
0.78 |
chr20_60638817_60639672 | 0.94 |
ENSG00000265306 |
. |
614 |
0.65 |
chr20_6103717_6104189 | 0.94 |
FERMT1 |
fermitin family member 1 |
238 |
0.95 |
chr15_47476270_47477144 | 0.94 |
SEMA6D |
sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6D |
409 |
0.87 |
chr6_34205466_34206794 | 0.94 |
HMGA1 |
high mobility group AT-hook 1 |
438 |
0.85 |
chr15_48937037_48938293 | 0.94 |
FBN1 |
fibrillin 1 |
253 |
0.95 |
chr8_72459619_72459990 | 0.94 |
RP11-1102P16.1 |
Uncharacterized protein |
88 |
0.98 |
chr10_11784750_11785238 | 0.94 |
ECHDC3 |
enoyl CoA hydratase domain containing 3 |
549 |
0.83 |
chr9_84303354_84304234 | 0.94 |
TLE1 |
transducin-like enhancer of split 1 (E(sp1) homolog, Drosophila) |
198 |
0.96 |
chr8_23260918_23261191 | 0.93 |
LOXL2 |
lysyl oxidase-like 2 |
535 |
0.78 |
chr1_242688162_242688638 | 0.93 |
PLD5 |
phospholipase D family, member 5 |
402 |
0.92 |
chr17_38500769_38502147 | 0.93 |
RARA |
retinoic acid receptor, alpha |
35 |
0.95 |
chr1_120189851_120190681 | 0.93 |
ZNF697 |
zinc finger protein 697 |
130 |
0.97 |
chr3_184286801_184287672 | 0.93 |
EPHB3 |
EPH receptor B3 |
7664 |
0.2 |
chr10_101088892_101089952 | 0.93 |
CNNM1 |
cyclin M1 |
266 |
0.95 |
chr11_120894558_120895785 | 0.92 |
TBCEL |
tubulin folding cofactor E-like |
341 |
0.93 |
chr18_55469401_55470160 | 0.92 |
ATP8B1 |
ATPase, aminophospholipid transporter, class I, type 8B, member 1 |
547 |
0.82 |
chr22_45899514_45899973 | 0.92 |
FBLN1 |
fibulin 1 |
817 |
0.67 |
chr3_56501877_56502361 | 0.92 |
ERC2 |
ELKS/RAB6-interacting/CAST family member 2 |
272 |
0.95 |
chr3_128207705_128209147 | 0.91 |
RP11-475N22.4 |
|
326 |
0.79 |
chr1_112532383_112532987 | 0.90 |
KCND3 |
potassium voltage-gated channel, Shal-related subfamily, member 3 |
908 |
0.69 |
chr15_99192776_99194432 | 0.90 |
IGF1R |
insulin-like growth factor 1 receptor |
1331 |
0.47 |
chr22_18051179_18051572 | 0.90 |
SLC25A18 |
solute carrier family 25 (glutamate carrier), member 18 |
8225 |
0.18 |
chr11_27740485_27740934 | 0.90 |
BDNF |
brain-derived neurotrophic factor |
585 |
0.82 |
chr16_88449218_88449497 | 0.90 |
ZNF469 |
zinc finger protein 469 |
44522 |
0.14 |
chr3_123168721_123169253 | 0.90 |
ADCY5 |
adenylate cyclase 5 |
382 |
0.9 |
chr5_178771678_178772082 | 0.90 |
ADAMTS2 |
ADAM metallopeptidase with thrombospondin type 1 motif, 2 |
551 |
0.84 |
chr16_578205_579384 | 0.90 |
CAPN15 |
calpain 15 |
938 |
0.34 |
chr13_21295723_21296224 | 0.89 |
ENSG00000265710 |
. |
18131 |
0.18 |
chr12_66123171_66123387 | 0.89 |
HMGA2 |
high mobility group AT-hook 2 |
94632 |
0.08 |
chr8_18871547_18872047 | 0.89 |
PSD3 |
pleckstrin and Sec7 domain containing 3 |
601 |
0.78 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.1 | 2.2 | GO:0060677 | ureteric bud elongation(GO:0060677) |
1.1 | 3.2 | GO:0060686 | negative regulation of prostatic bud formation(GO:0060686) |
1.0 | 3.1 | GO:0061364 | apoptotic process involved in luteolysis(GO:0061364) |
0.8 | 1.6 | GO:0002043 | blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:0002043) |
0.8 | 2.4 | GO:0055098 | response to low-density lipoprotein particle(GO:0055098) |
0.7 | 3.0 | GO:0060737 | prostate gland morphogenetic growth(GO:0060737) |
0.7 | 2.9 | GO:0072070 | loop of Henle development(GO:0072070) |
0.7 | 2.0 | GO:0051451 | myoblast migration(GO:0051451) |
0.7 | 3.3 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
0.7 | 2.6 | GO:0045662 | negative regulation of myoblast differentiation(GO:0045662) |
0.6 | 1.2 | GO:0071502 | cellular response to temperature stimulus(GO:0071502) |
0.6 | 1.2 | GO:0002072 | optic cup morphogenesis involved in camera-type eye development(GO:0002072) |
0.6 | 1.7 | GO:0060083 | smooth muscle contraction involved in micturition(GO:0060083) |
0.6 | 2.8 | GO:0014034 | neural crest formation(GO:0014029) neural crest cell fate commitment(GO:0014034) |
0.6 | 1.7 | GO:0060839 | endothelial cell fate commitment(GO:0060839) |
0.5 | 2.1 | GO:0021978 | telencephalon regionalization(GO:0021978) |
0.5 | 4.1 | GO:0033327 | Leydig cell differentiation(GO:0033327) |
0.5 | 1.0 | GO:0021798 | forebrain dorsal/ventral pattern formation(GO:0021798) |
0.5 | 1.5 | GO:1900116 | sequestering of extracellular ligand from receptor(GO:0035581) sequestering of TGFbeta in extracellular matrix(GO:0035583) protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) extracellular regulation of signal transduction(GO:1900115) extracellular negative regulation of signal transduction(GO:1900116) |
0.4 | 1.3 | GO:0060684 | epithelial-mesenchymal cell signaling(GO:0060684) |
0.4 | 0.9 | GO:0030538 | embryonic genitalia morphogenesis(GO:0030538) |
0.4 | 1.3 | GO:0010757 | negative regulation of plasminogen activation(GO:0010757) |
0.4 | 1.3 | GO:0016103 | diterpenoid catabolic process(GO:0016103) terpenoid catabolic process(GO:0016115) retinoic acid catabolic process(GO:0034653) |
0.4 | 1.3 | GO:0032344 | regulation of ketone biosynthetic process(GO:0010566) regulation of aldosterone metabolic process(GO:0032344) regulation of aldosterone biosynthetic process(GO:0032347) |
0.4 | 1.3 | GO:0009648 | photoperiodism(GO:0009648) |
0.4 | 1.3 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) 4-hydroxyproline metabolic process(GO:0019471) peptidyl-proline hydroxylation(GO:0019511) |
0.4 | 0.8 | GO:0003148 | outflow tract septum morphogenesis(GO:0003148) |
0.4 | 0.8 | GO:0061004 | pattern specification involved in kidney development(GO:0061004) renal system pattern specification(GO:0072048) pattern specification involved in metanephros development(GO:0072268) |
0.4 | 0.4 | GO:0050923 | Roundabout signaling pathway(GO:0035385) regulation of negative chemotaxis(GO:0050923) |
0.4 | 1.2 | GO:0021563 | glossopharyngeal nerve development(GO:0021563) glossopharyngeal nerve morphogenesis(GO:0021615) |
0.4 | 1.2 | GO:0034201 | response to oleic acid(GO:0034201) |
0.4 | 0.4 | GO:0032469 | endoplasmic reticulum calcium ion homeostasis(GO:0032469) |
0.4 | 1.6 | GO:0014012 | peripheral nervous system axon regeneration(GO:0014012) |
0.4 | 0.4 | GO:0021800 | cerebral cortex tangential migration(GO:0021800) |
0.4 | 0.4 | GO:0060685 | regulation of prostatic bud formation(GO:0060685) |
0.4 | 1.2 | GO:0061072 | iris morphogenesis(GO:0061072) |
0.4 | 0.4 | GO:0060039 | pericardium development(GO:0060039) |
0.4 | 1.2 | GO:0015820 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
0.4 | 1.5 | GO:0061029 | eyelid development in camera-type eye(GO:0061029) |
0.4 | 1.1 | GO:0071883 | adrenergic receptor signaling pathway(GO:0071875) activation of MAPK activity by adrenergic receptor signaling pathway(GO:0071883) |
0.4 | 1.1 | GO:0033088 | negative regulation of immature T cell proliferation(GO:0033087) negative regulation of immature T cell proliferation in thymus(GO:0033088) |
0.4 | 0.8 | GO:0060453 | regulation of gastric acid secretion(GO:0060453) |
0.4 | 1.5 | GO:0071364 | cellular response to epidermal growth factor stimulus(GO:0071364) |
0.4 | 1.5 | GO:0060573 | ventral spinal cord interneuron specification(GO:0021521) cell fate specification involved in pattern specification(GO:0060573) |
0.4 | 1.1 | GO:0003099 | positive regulation of the force of heart contraction by chemical signal(GO:0003099) |
0.4 | 1.4 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
0.4 | 1.1 | GO:0045112 | integrin biosynthetic process(GO:0045112) |
0.3 | 0.7 | GO:0045077 | negative regulation of interferon-gamma biosynthetic process(GO:0045077) |
0.3 | 0.7 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
0.3 | 1.0 | GO:0021555 | midbrain-hindbrain boundary morphogenesis(GO:0021555) |
0.3 | 1.0 | GO:0045162 | clustering of voltage-gated sodium channels(GO:0045162) |
0.3 | 1.0 | GO:0010837 | regulation of keratinocyte proliferation(GO:0010837) |
0.3 | 1.0 | GO:0048319 | axial mesoderm morphogenesis(GO:0048319) |
0.3 | 0.7 | GO:0060437 | lung growth(GO:0060437) |
0.3 | 0.7 | GO:0051580 | regulation of neurotransmitter uptake(GO:0051580) regulation of dopamine uptake involved in synaptic transmission(GO:0051584) regulation of catecholamine uptake involved in synaptic transmission(GO:0051940) |
0.3 | 1.3 | GO:0008218 | bioluminescence(GO:0008218) |
0.3 | 1.6 | GO:0043129 | surfactant homeostasis(GO:0043129) chemical homeostasis within a tissue(GO:0048875) |
0.3 | 0.7 | GO:0070172 | positive regulation of tooth mineralization(GO:0070172) |
0.3 | 0.3 | GO:0021871 | forebrain regionalization(GO:0021871) |
0.3 | 1.0 | GO:0014820 | tonic smooth muscle contraction(GO:0014820) artery smooth muscle contraction(GO:0014824) |
0.3 | 1.0 | GO:0016080 | synaptic vesicle targeting(GO:0016080) |
0.3 | 1.3 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
0.3 | 1.0 | GO:0070092 | regulation of glucagon secretion(GO:0070092) |
0.3 | 0.6 | GO:0048808 | male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
0.3 | 1.3 | GO:0021894 | interneuron migration from the subpallium to the cortex(GO:0021830) cerebral cortex GABAergic interneuron migration(GO:0021853) cerebral cortex GABAergic interneuron development(GO:0021894) interneuron migration(GO:1904936) |
0.3 | 0.6 | GO:0060068 | vagina development(GO:0060068) |
0.3 | 0.9 | GO:1901889 | negative regulation of focal adhesion assembly(GO:0051895) negative regulation of cell junction assembly(GO:1901889) negative regulation of adherens junction organization(GO:1903392) |
0.3 | 0.9 | GO:0001705 | ectoderm formation(GO:0001705) |
0.3 | 3.3 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.3 | 1.2 | GO:0000098 | sulfur amino acid catabolic process(GO:0000098) |
0.3 | 0.6 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
0.3 | 0.9 | GO:0046882 | negative regulation of follicle-stimulating hormone secretion(GO:0046882) |
0.3 | 1.2 | GO:0046322 | negative regulation of fatty acid oxidation(GO:0046322) |
0.3 | 0.9 | GO:0035234 | ectopic germ cell programmed cell death(GO:0035234) |
0.3 | 0.6 | GO:0003171 | atrioventricular valve development(GO:0003171) atrioventricular valve morphogenesis(GO:0003181) |
0.3 | 0.9 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.3 | 1.1 | GO:0002551 | mast cell chemotaxis(GO:0002551) regulation of mast cell chemotaxis(GO:0060753) positive regulation of mast cell chemotaxis(GO:0060754) mast cell migration(GO:0097531) |
0.3 | 1.1 | GO:0043589 | skin morphogenesis(GO:0043589) |
0.3 | 0.8 | GO:0048867 | stem cell fate commitment(GO:0048865) stem cell fate determination(GO:0048867) |
0.3 | 0.3 | GO:0007352 | zygotic specification of dorsal/ventral axis(GO:0007352) |
0.3 | 0.6 | GO:0021892 | cerebral cortex GABAergic interneuron differentiation(GO:0021892) |
0.3 | 0.8 | GO:0048170 | positive regulation of long-term neuronal synaptic plasticity(GO:0048170) |
0.3 | 0.8 | GO:0009756 | carbohydrate mediated signaling(GO:0009756) |
0.3 | 1.1 | GO:0071731 | response to nitric oxide(GO:0071731) |
0.3 | 0.3 | GO:0042637 | catagen(GO:0042637) |
0.3 | 0.8 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
0.3 | 1.3 | GO:0010544 | negative regulation of platelet activation(GO:0010544) |
0.3 | 1.9 | GO:0034446 | substrate adhesion-dependent cell spreading(GO:0034446) |
0.3 | 1.6 | GO:0021952 | central nervous system projection neuron axonogenesis(GO:0021952) |
0.3 | 0.3 | GO:0046084 | adenine salvage(GO:0006168) purine nucleobase salvage(GO:0043096) adenine metabolic process(GO:0046083) adenine biosynthetic process(GO:0046084) |
0.3 | 0.8 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
0.3 | 0.3 | GO:0010701 | positive regulation of norepinephrine secretion(GO:0010701) |
0.3 | 0.5 | GO:0042670 | retinal cone cell differentiation(GO:0042670) retinal cone cell development(GO:0046549) |
0.3 | 1.5 | GO:0015871 | choline transport(GO:0015871) |
0.3 | 1.3 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
0.3 | 0.8 | GO:0070874 | negative regulation of glycogen metabolic process(GO:0070874) |
0.2 | 0.5 | GO:0007500 | mesodermal cell fate determination(GO:0007500) |
0.2 | 3.2 | GO:0035088 | establishment or maintenance of apical/basal cell polarity(GO:0035088) establishment or maintenance of bipolar cell polarity(GO:0061245) |
0.2 | 0.2 | GO:0060602 | branch elongation of an epithelium(GO:0060602) |
0.2 | 0.2 | GO:0090103 | cochlea morphogenesis(GO:0090103) |
0.2 | 0.7 | GO:0051014 | actin filament severing(GO:0051014) |
0.2 | 2.2 | GO:0017187 | peptidyl-glutamic acid carboxylation(GO:0017187) protein carboxylation(GO:0018214) |
0.2 | 1.0 | GO:0021571 | rhombomere 5 development(GO:0021571) |
0.2 | 1.2 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.2 | 1.4 | GO:0033137 | negative regulation of peptidyl-serine phosphorylation(GO:0033137) |
0.2 | 0.9 | GO:0032455 | nerve growth factor processing(GO:0032455) |
0.2 | 0.9 | GO:0007195 | adenylate cyclase-inhibiting dopamine receptor signaling pathway(GO:0007195) |
0.2 | 0.5 | GO:0003010 | voluntary skeletal muscle contraction(GO:0003010) twitch skeletal muscle contraction(GO:0014721) |
0.2 | 0.5 | GO:0033688 | regulation of osteoblast proliferation(GO:0033688) |
0.2 | 0.7 | GO:0010216 | maintenance of DNA methylation(GO:0010216) |
0.2 | 0.7 | GO:0036303 | lymphangiogenesis(GO:0001946) lymph vessel morphogenesis(GO:0036303) |
0.2 | 0.7 | GO:0045767 | obsolete regulation of anti-apoptosis(GO:0045767) |
0.2 | 0.4 | GO:0002118 | aggressive behavior(GO:0002118) |
0.2 | 0.2 | GO:0061140 | lung secretory cell differentiation(GO:0061140) |
0.2 | 0.4 | GO:0036072 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.2 | 2.9 | GO:0035329 | hippo signaling(GO:0035329) |
0.2 | 0.7 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
0.2 | 0.7 | GO:0046469 | platelet activating factor biosynthetic process(GO:0006663) platelet activating factor metabolic process(GO:0046469) |
0.2 | 0.7 | GO:0010891 | negative regulation of sequestering of triglyceride(GO:0010891) |
0.2 | 0.9 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.2 | 0.4 | GO:0003215 | cardiac right ventricle morphogenesis(GO:0003215) |
0.2 | 1.3 | GO:0031272 | pseudopodium assembly(GO:0031269) regulation of pseudopodium assembly(GO:0031272) positive regulation of pseudopodium assembly(GO:0031274) |
0.2 | 1.5 | GO:0060314 | regulation of ryanodine-sensitive calcium-release channel activity(GO:0060314) |
0.2 | 0.4 | GO:0048485 | sympathetic nervous system development(GO:0048485) |
0.2 | 0.6 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.2 | 0.6 | GO:0003321 | positive regulation of blood pressure by epinephrine-norepinephrine(GO:0003321) |
0.2 | 0.2 | GO:0060992 | response to fungicide(GO:0060992) |
0.2 | 0.4 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
0.2 | 0.2 | GO:0045617 | negative regulation of keratinocyte differentiation(GO:0045617) |
0.2 | 0.6 | GO:1904377 | positive regulation of establishment of protein localization to plasma membrane(GO:0090004) positive regulation of protein localization to plasma membrane(GO:1903078) positive regulation of protein localization to cell periphery(GO:1904377) |
0.2 | 2.2 | GO:0042474 | middle ear morphogenesis(GO:0042474) |
0.2 | 0.4 | GO:0060438 | trachea development(GO:0060438) |
0.2 | 0.6 | GO:0000966 | RNA 5'-end processing(GO:0000966) |
0.2 | 0.2 | GO:0010803 | regulation of tumor necrosis factor-mediated signaling pathway(GO:0010803) |
0.2 | 0.8 | GO:0060008 | Sertoli cell differentiation(GO:0060008) |
0.2 | 0.4 | GO:0032060 | bleb assembly(GO:0032060) |
0.2 | 3.2 | GO:0009954 | proximal/distal pattern formation(GO:0009954) |
0.2 | 1.0 | GO:0060347 | heart trabecula formation(GO:0060347) heart trabecula morphogenesis(GO:0061384) |
0.2 | 0.2 | GO:0060748 | tertiary branching involved in mammary gland duct morphogenesis(GO:0060748) |
0.2 | 0.8 | GO:0060013 | righting reflex(GO:0060013) |
0.2 | 0.4 | GO:0070141 | response to UV-A(GO:0070141) |
0.2 | 0.6 | GO:0032236 | obsolete positive regulation of calcium ion transport via store-operated calcium channel activity(GO:0032236) |
0.2 | 0.8 | GO:0090025 | regulation of monocyte chemotaxis(GO:0090025) positive regulation of monocyte chemotaxis(GO:0090026) |
0.2 | 0.2 | GO:0060323 | head morphogenesis(GO:0060323) |
0.2 | 0.9 | GO:0021781 | glial cell fate commitment(GO:0021781) |
0.2 | 0.9 | GO:0030033 | microvillus assembly(GO:0030033) microvillus organization(GO:0032528) |
0.2 | 0.6 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
0.2 | 0.2 | GO:2001279 | regulation of prostaglandin biosynthetic process(GO:0031392) positive regulation of prostaglandin biosynthetic process(GO:0031394) regulation of unsaturated fatty acid biosynthetic process(GO:2001279) positive regulation of unsaturated fatty acid biosynthetic process(GO:2001280) |
0.2 | 0.6 | GO:0002068 | glandular epithelial cell development(GO:0002068) |
0.2 | 0.6 | GO:0008215 | spermine metabolic process(GO:0008215) |
0.2 | 1.7 | GO:0019369 | arachidonic acid metabolic process(GO:0019369) |
0.2 | 0.2 | GO:0060028 | convergent extension involved in axis elongation(GO:0060028) |
0.2 | 1.3 | GO:0042249 | establishment of planar polarity of embryonic epithelium(GO:0042249) |
0.2 | 0.4 | GO:0021932 | hindbrain radial glia guided cell migration(GO:0021932) |
0.2 | 0.9 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
0.2 | 0.7 | GO:0048013 | ephrin receptor signaling pathway(GO:0048013) |
0.2 | 0.2 | GO:0060174 | limb bud formation(GO:0060174) |
0.2 | 0.2 | GO:0072179 | nephric duct formation(GO:0072179) |
0.2 | 0.5 | GO:2000178 | negative regulation of neuroblast proliferation(GO:0007406) negative regulation of neural precursor cell proliferation(GO:2000178) |
0.2 | 0.2 | GO:0048715 | negative regulation of oligodendrocyte differentiation(GO:0048715) |
0.2 | 0.5 | GO:0048702 | embryonic neurocranium morphogenesis(GO:0048702) |
0.2 | 0.2 | GO:0032098 | regulation of appetite(GO:0032098) |
0.2 | 0.5 | GO:0016081 | synaptic vesicle docking(GO:0016081) |
0.2 | 0.5 | GO:0010842 | retina layer formation(GO:0010842) |
0.2 | 1.0 | GO:2000179 | positive regulation of neural precursor cell proliferation(GO:2000179) |
0.2 | 0.7 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) chloride ion homeostasis(GO:0055064) |
0.2 | 0.3 | GO:0022601 | menstrual cycle phase(GO:0022601) |
0.2 | 0.2 | GO:0060435 | bronchiole development(GO:0060435) |
0.2 | 0.5 | GO:0003351 | epithelial cilium movement(GO:0003351) epithelial cilium movement involved in determination of left/right asymmetry(GO:0060287) |
0.2 | 0.7 | GO:0015868 | purine ribonucleotide transport(GO:0015868) |
0.2 | 2.8 | GO:0030199 | collagen fibril organization(GO:0030199) |
0.2 | 0.5 | GO:0021683 | cerebellar granular layer development(GO:0021681) cerebellar granular layer morphogenesis(GO:0021683) cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
0.2 | 0.2 | GO:0060061 | Spemann organizer formation(GO:0060061) |
0.2 | 0.2 | GO:2000189 | regulation of cholesterol homeostasis(GO:2000188) positive regulation of cholesterol homeostasis(GO:2000189) |
0.2 | 0.3 | GO:0022605 | oogenesis stage(GO:0022605) |
0.2 | 0.3 | GO:2000192 | negative regulation of plasma membrane long-chain fatty acid transport(GO:0010748) negative regulation of anion transmembrane transport(GO:1903960) negative regulation of fatty acid transport(GO:2000192) |
0.2 | 0.8 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
0.2 | 1.6 | GO:0021983 | pituitary gland development(GO:0021983) |
0.2 | 0.6 | GO:0051894 | positive regulation of focal adhesion assembly(GO:0051894) positive regulation of cell junction assembly(GO:1901890) positive regulation of adherens junction organization(GO:1903393) |
0.2 | 0.3 | GO:0032331 | negative regulation of chondrocyte differentiation(GO:0032331) |
0.2 | 0.5 | GO:0035461 | vitamin transmembrane transport(GO:0035461) |
0.2 | 0.8 | GO:0051898 | negative regulation of protein kinase B signaling(GO:0051898) |
0.2 | 0.5 | GO:0015864 | pyrimidine nucleoside transport(GO:0015864) |
0.2 | 1.7 | GO:0035115 | embryonic forelimb morphogenesis(GO:0035115) |
0.2 | 0.3 | GO:0051150 | regulation of smooth muscle cell differentiation(GO:0051150) |
0.2 | 0.2 | GO:0070254 | mucus secretion(GO:0070254) |
0.1 | 0.3 | GO:0060605 | tube lumen cavitation(GO:0060605) salivary gland cavitation(GO:0060662) |
0.1 | 0.7 | GO:0042983 | amyloid precursor protein biosynthetic process(GO:0042983) regulation of amyloid precursor protein biosynthetic process(GO:0042984) |
0.1 | 2.1 | GO:0048010 | vascular endothelial growth factor receptor signaling pathway(GO:0048010) |
0.1 | 0.1 | GO:0051891 | positive regulation of cardioblast differentiation(GO:0051891) positive regulation of cardiocyte differentiation(GO:1905209) |
0.1 | 0.4 | GO:0031943 | regulation of glucocorticoid metabolic process(GO:0031943) |
0.1 | 0.1 | GO:0001945 | lymph vessel development(GO:0001945) |
0.1 | 0.4 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
0.1 | 0.1 | GO:0048520 | positive regulation of behavior(GO:0048520) |
0.1 | 0.4 | GO:0071392 | cellular response to estradiol stimulus(GO:0071392) |
0.1 | 0.7 | GO:0010889 | regulation of sequestering of triglyceride(GO:0010889) |
0.1 | 0.4 | GO:0045906 | negative regulation of vasoconstriction(GO:0045906) |
0.1 | 0.4 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
0.1 | 0.9 | GO:0051281 | positive regulation of release of sequestered calcium ion into cytosol(GO:0051281) positive regulation of calcium ion import(GO:0090280) |
0.1 | 1.3 | GO:0045600 | positive regulation of fat cell differentiation(GO:0045600) |
0.1 | 1.8 | GO:0045907 | positive regulation of vasoconstriction(GO:0045907) |
0.1 | 1.0 | GO:0009404 | toxin metabolic process(GO:0009404) |
0.1 | 0.4 | GO:0006526 | arginine biosynthetic process(GO:0006526) |
0.1 | 0.6 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
0.1 | 1.3 | GO:0021516 | dorsal spinal cord development(GO:0021516) |
0.1 | 0.3 | GO:0002887 | negative regulation of myeloid leukocyte mediated immunity(GO:0002887) negative regulation of leukocyte degranulation(GO:0043301) |
0.1 | 0.3 | GO:0071294 | cellular response to zinc ion(GO:0071294) |
0.1 | 0.4 | GO:0045880 | positive regulation of smoothened signaling pathway(GO:0045880) |
0.1 | 1.4 | GO:0048008 | platelet-derived growth factor receptor signaling pathway(GO:0048008) |
0.1 | 0.3 | GO:0010523 | negative regulation of calcium ion transport into cytosol(GO:0010523) |
0.1 | 0.3 | GO:0060592 | mammary gland formation(GO:0060592) mammary placode formation(GO:0060596) |
0.1 | 1.7 | GO:0010633 | negative regulation of epithelial cell migration(GO:0010633) |
0.1 | 1.0 | GO:0002281 | macrophage activation involved in immune response(GO:0002281) |
0.1 | 0.4 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) protein O-linked glycosylation via threonine(GO:0018243) |
0.1 | 0.3 | GO:0006591 | ornithine metabolic process(GO:0006591) |
0.1 | 0.1 | GO:0048617 | foregut morphogenesis(GO:0007440) embryonic foregut morphogenesis(GO:0048617) |
0.1 | 0.7 | GO:0071445 | obsolete cellular response to protein stimulus(GO:0071445) |
0.1 | 0.1 | GO:0060065 | uterus development(GO:0060065) |
0.1 | 1.0 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
0.1 | 1.5 | GO:0007263 | nitric oxide mediated signal transduction(GO:0007263) |
0.1 | 1.2 | GO:0061098 | positive regulation of protein tyrosine kinase activity(GO:0061098) |
0.1 | 1.4 | GO:0046697 | decidualization(GO:0046697) |
0.1 | 2.2 | GO:0045103 | intermediate filament-based process(GO:0045103) |
0.1 | 0.4 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
0.1 | 0.4 | GO:0048289 | isotype switching to IgE isotypes(GO:0048289) regulation of isotype switching to IgE isotypes(GO:0048293) |
0.1 | 0.3 | GO:0014819 | regulation of skeletal muscle contraction(GO:0014819) |
0.1 | 0.7 | GO:0007350 | blastoderm segmentation(GO:0007350) |
0.1 | 0.8 | GO:0007616 | long-term memory(GO:0007616) |
0.1 | 0.3 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
0.1 | 0.4 | GO:0051387 | negative regulation of neurotrophin TRK receptor signaling pathway(GO:0051387) |
0.1 | 0.4 | GO:0050703 | interleukin-1 alpha secretion(GO:0050703) |
0.1 | 0.4 | GO:0048566 | embryonic digestive tract development(GO:0048566) |
0.1 | 0.5 | GO:0045663 | positive regulation of myoblast differentiation(GO:0045663) |
0.1 | 0.1 | GO:2000273 | positive regulation of receptor activity(GO:2000273) |
0.1 | 0.1 | GO:0050942 | positive regulation of melanocyte differentiation(GO:0045636) positive regulation of pigment cell differentiation(GO:0050942) |
0.1 | 1.3 | GO:0008038 | neuron recognition(GO:0008038) |
0.1 | 0.3 | GO:0042487 | regulation of odontogenesis of dentin-containing tooth(GO:0042487) |
0.1 | 0.1 | GO:0046386 | deoxyribose phosphate catabolic process(GO:0046386) |
0.1 | 0.3 | GO:0015732 | prostaglandin transport(GO:0015732) |
0.1 | 0.9 | GO:0006198 | cAMP catabolic process(GO:0006198) |
0.1 | 0.9 | GO:0035510 | DNA dealkylation(GO:0035510) |
0.1 | 0.6 | GO:0033599 | regulation of mammary gland epithelial cell proliferation(GO:0033599) |
0.1 | 0.5 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
0.1 | 0.5 | GO:2000258 | negative regulation of humoral immune response(GO:0002921) negative regulation of complement activation(GO:0045916) negative regulation of protein activation cascade(GO:2000258) |
0.1 | 1.9 | GO:0016525 | negative regulation of angiogenesis(GO:0016525) |
0.1 | 1.1 | GO:0046716 | muscle cell cellular homeostasis(GO:0046716) |
0.1 | 0.4 | GO:0046502 | uroporphyrinogen III metabolic process(GO:0046502) |
0.1 | 0.1 | GO:0044266 | multicellular organismal protein catabolic process(GO:0044254) protein digestion(GO:0044256) multicellular organismal macromolecule catabolic process(GO:0044266) multicellular organismal protein metabolic process(GO:0044268) |
0.1 | 0.1 | GO:0090206 | negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
0.1 | 1.2 | GO:0007528 | neuromuscular junction development(GO:0007528) |
0.1 | 0.5 | GO:0050435 | beta-amyloid metabolic process(GO:0050435) |
0.1 | 0.1 | GO:0042482 | positive regulation of odontogenesis(GO:0042482) |
0.1 | 0.2 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
0.1 | 0.2 | GO:0001554 | luteolysis(GO:0001554) |
0.1 | 0.5 | GO:0045542 | positive regulation of cholesterol biosynthetic process(GO:0045542) |
0.1 | 0.2 | GO:0043587 | tongue morphogenesis(GO:0043587) |
0.1 | 0.2 | GO:0042268 | regulation of cytolysis(GO:0042268) |
0.1 | 0.5 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
0.1 | 0.3 | GO:0007191 | adenylate cyclase-activating dopamine receptor signaling pathway(GO:0007191) |
0.1 | 0.1 | GO:0045683 | negative regulation of epidermal cell differentiation(GO:0045605) negative regulation of epidermis development(GO:0045683) |
0.1 | 1.1 | GO:0098743 | cartilage condensation(GO:0001502) cell aggregation(GO:0098743) |
0.1 | 0.3 | GO:0070306 | lens fiber cell differentiation(GO:0070306) |
0.1 | 0.6 | GO:0001738 | morphogenesis of a polarized epithelium(GO:0001738) |
0.1 | 0.3 | GO:0043312 | neutrophil activation involved in immune response(GO:0002283) neutrophil degranulation(GO:0043312) |
0.1 | 0.2 | GO:0001893 | maternal placenta development(GO:0001893) |
0.1 | 2.5 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
0.1 | 0.9 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
0.1 | 0.2 | GO:0042219 | cellular modified amino acid catabolic process(GO:0042219) |
0.1 | 0.3 | GO:0048799 | organ maturation(GO:0048799) bone maturation(GO:0070977) |
0.1 | 0.3 | GO:0051497 | negative regulation of stress fiber assembly(GO:0051497) |
0.1 | 0.1 | GO:0014850 | response to muscle activity(GO:0014850) |
0.1 | 0.4 | GO:0046113 | nucleobase catabolic process(GO:0046113) |
0.1 | 1.0 | GO:0047496 | vesicle transport along microtubule(GO:0047496) vesicle cytoskeletal trafficking(GO:0099518) |
0.1 | 0.8 | GO:0051492 | regulation of stress fiber assembly(GO:0051492) |
0.1 | 1.2 | GO:0006893 | Golgi to plasma membrane transport(GO:0006893) vesicle-mediated transport to the plasma membrane(GO:0098876) |
0.1 | 1.0 | GO:0046718 | viral entry into host cell(GO:0046718) |
0.1 | 0.5 | GO:0046839 | phospholipid dephosphorylation(GO:0046839) |
0.1 | 0.5 | GO:0008347 | glial cell migration(GO:0008347) |
0.1 | 0.3 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.1 | 0.3 | GO:0021873 | forebrain neuroblast division(GO:0021873) |
0.1 | 0.5 | GO:0015802 | basic amino acid transport(GO:0015802) |
0.1 | 0.2 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
0.1 | 1.9 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
0.1 | 0.1 | GO:0016198 | axon choice point recognition(GO:0016198) |
0.1 | 0.2 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
0.1 | 0.1 | GO:0051541 | elastin metabolic process(GO:0051541) |
0.1 | 0.4 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.1 | 13.0 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.1 | 0.2 | GO:0072201 | negative regulation of mesenchymal cell proliferation(GO:0072201) |
0.1 | 0.8 | GO:0007398 | ectoderm development(GO:0007398) |
0.1 | 0.4 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
0.1 | 0.3 | GO:0005984 | disaccharide metabolic process(GO:0005984) |
0.1 | 0.9 | GO:0007405 | neuroblast proliferation(GO:0007405) |
0.1 | 0.3 | GO:0048488 | synaptic vesicle recycling(GO:0036465) synaptic vesicle endocytosis(GO:0048488) clathrin-mediated endocytosis(GO:0072583) |
0.1 | 0.2 | GO:0036336 | dendritic cell chemotaxis(GO:0002407) dendritic cell migration(GO:0036336) |
0.1 | 0.1 | GO:0007494 | midgut development(GO:0007494) |
0.1 | 0.2 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
0.1 | 0.2 | GO:0043113 | receptor clustering(GO:0043113) |
0.1 | 0.2 | GO:0090102 | cochlea development(GO:0090102) |
0.1 | 0.1 | GO:0009214 | cyclic nucleotide catabolic process(GO:0009214) |
0.1 | 0.1 | GO:0003157 | endocardium development(GO:0003157) endocardium morphogenesis(GO:0003160) endocardium formation(GO:0060214) |
0.1 | 0.7 | GO:0032376 | positive regulation of sterol transport(GO:0032373) positive regulation of cholesterol transport(GO:0032376) |
0.1 | 0.1 | GO:0002066 | columnar/cuboidal epithelial cell development(GO:0002066) |
0.1 | 0.3 | GO:0098810 | neurotransmitter reuptake(GO:0098810) |
0.1 | 0.1 | GO:0030104 | water homeostasis(GO:0030104) |
0.1 | 0.1 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
0.1 | 0.4 | GO:0071398 | cellular response to fatty acid(GO:0071398) |
0.1 | 0.5 | GO:0030325 | adrenal gland development(GO:0030325) |
0.1 | 1.4 | GO:1901224 | activation of NF-kappaB-inducing kinase activity(GO:0007250) NIK/NF-kappaB signaling(GO:0038061) regulation of NIK/NF-kappaB signaling(GO:1901222) positive regulation of NIK/NF-kappaB signaling(GO:1901224) |
0.1 | 0.2 | GO:0014911 | positive regulation of smooth muscle cell migration(GO:0014911) |
0.1 | 0.8 | GO:0007274 | neuromuscular synaptic transmission(GO:0007274) |
0.1 | 1.6 | GO:0048704 | embryonic skeletal system morphogenesis(GO:0048704) |
0.1 | 1.7 | GO:0017158 | regulation of calcium ion-dependent exocytosis(GO:0017158) |
0.1 | 0.3 | GO:0017121 | phospholipid scrambling(GO:0017121) |
0.1 | 0.8 | GO:0007143 | female meiotic division(GO:0007143) |
0.1 | 0.7 | GO:0099504 | synaptic vesicle cycle(GO:0099504) |
0.1 | 0.2 | GO:0019919 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) |
0.1 | 0.1 | GO:0001992 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
0.1 | 0.2 | GO:0032227 | negative regulation of synaptic transmission, dopaminergic(GO:0032227) |
0.1 | 0.5 | GO:0006975 | DNA damage induced protein phosphorylation(GO:0006975) |
0.1 | 0.3 | GO:0070528 | protein kinase C signaling(GO:0070528) |
0.1 | 0.1 | GO:0031223 | response to auditory stimulus(GO:0010996) auditory behavior(GO:0031223) |
0.1 | 0.1 | GO:0045603 | positive regulation of endothelial cell differentiation(GO:0045603) |
0.1 | 0.2 | GO:1902284 | axon extension involved in axon guidance(GO:0048846) neuron projection extension involved in neuron projection guidance(GO:1902284) |
0.1 | 0.4 | GO:0002089 | lens morphogenesis in camera-type eye(GO:0002089) |
0.1 | 0.3 | GO:0046475 | phosphatidylcholine catabolic process(GO:0034638) glycerophospholipid catabolic process(GO:0046475) |
0.1 | 0.2 | GO:0010765 | positive regulation of sodium ion transport(GO:0010765) |
0.1 | 1.5 | GO:0098773 | hair follicle development(GO:0001942) molting cycle process(GO:0022404) hair cycle process(GO:0022405) skin epidermis development(GO:0098773) |
0.1 | 0.8 | GO:0090659 | adult walking behavior(GO:0007628) walking behavior(GO:0090659) |
0.1 | 0.3 | GO:0036075 | endochondral ossification(GO:0001958) replacement ossification(GO:0036075) |
0.1 | 1.6 | GO:0030512 | negative regulation of transforming growth factor beta receptor signaling pathway(GO:0030512) negative regulation of cellular response to transforming growth factor beta stimulus(GO:1903845) |
0.1 | 0.1 | GO:0048713 | regulation of oligodendrocyte differentiation(GO:0048713) |
0.1 | 0.5 | GO:0071300 | cellular response to retinoic acid(GO:0071300) |
0.1 | 0.4 | GO:0007185 | transmembrane receptor protein tyrosine phosphatase signaling pathway(GO:0007185) |
0.1 | 0.2 | GO:0046184 | aldehyde biosynthetic process(GO:0046184) |
0.1 | 0.2 | GO:0009415 | response to water deprivation(GO:0009414) response to water(GO:0009415) |
0.1 | 0.6 | GO:0045070 | positive regulation of viral genome replication(GO:0045070) |
0.1 | 2.0 | GO:0071805 | cellular potassium ion transport(GO:0071804) potassium ion transmembrane transport(GO:0071805) |
0.1 | 0.3 | GO:0051927 | obsolete negative regulation of calcium ion transport via voltage-gated calcium channel activity(GO:0051927) |
0.1 | 0.4 | GO:0002011 | morphogenesis of an epithelial sheet(GO:0002011) |
0.1 | 2.1 | GO:0046847 | filopodium assembly(GO:0046847) |
0.1 | 0.4 | GO:0001660 | fever generation(GO:0001660) |
0.1 | 1.0 | GO:0048168 | regulation of neuronal synaptic plasticity(GO:0048168) |
0.1 | 0.6 | GO:0045995 | regulation of embryonic development(GO:0045995) |
0.1 | 0.3 | GO:0006857 | oligopeptide transport(GO:0006857) |
0.1 | 0.1 | GO:0048148 | behavioral response to cocaine(GO:0048148) |
0.1 | 0.6 | GO:0006554 | lysine metabolic process(GO:0006553) lysine catabolic process(GO:0006554) |
0.1 | 0.6 | GO:0042135 | neurotransmitter catabolic process(GO:0042135) |
0.1 | 0.2 | GO:0003151 | outflow tract morphogenesis(GO:0003151) |
0.1 | 0.1 | GO:0033197 | response to vitamin E(GO:0033197) |
0.1 | 0.1 | GO:0071372 | cellular response to follicle-stimulating hormone stimulus(GO:0071372) |
0.1 | 0.1 | GO:0007207 | phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway(GO:0007207) |
0.1 | 0.7 | GO:0007215 | glutamate receptor signaling pathway(GO:0007215) |
0.1 | 0.5 | GO:0015904 | tetracycline transport(GO:0015904) |
0.1 | 3.3 | GO:0031424 | keratinization(GO:0031424) |
0.1 | 0.2 | GO:0018126 | protein hydroxylation(GO:0018126) |
0.1 | 0.3 | GO:0033261 | obsolete regulation of S phase(GO:0033261) |
0.1 | 0.2 | GO:0014821 | phasic smooth muscle contraction(GO:0014821) |
0.1 | 0.1 | GO:0048755 | branching morphogenesis of a nerve(GO:0048755) |
0.1 | 0.1 | GO:0009111 | vitamin catabolic process(GO:0009111) fat-soluble vitamin catabolic process(GO:0042363) |
0.1 | 0.4 | GO:0048663 | neuron fate commitment(GO:0048663) |
0.1 | 0.4 | GO:0050957 | equilibrioception(GO:0050957) |
0.1 | 0.2 | GO:0060393 | regulation of pathway-restricted SMAD protein phosphorylation(GO:0060393) |
0.1 | 0.3 | GO:0021884 | forebrain neuron development(GO:0021884) |
0.1 | 0.2 | GO:0045980 | negative regulation of nucleotide metabolic process(GO:0045980) |
0.1 | 0.1 | GO:0050955 | thermoception(GO:0050955) |
0.1 | 0.7 | GO:0032924 | activin receptor signaling pathway(GO:0032924) |
0.1 | 1.5 | GO:0006885 | regulation of pH(GO:0006885) |
0.1 | 0.2 | GO:0048630 | skeletal muscle tissue growth(GO:0048630) |
0.1 | 0.1 | GO:0060033 | anatomical structure regression(GO:0060033) |
0.1 | 0.3 | GO:0032095 | regulation of response to food(GO:0032095) |
0.1 | 0.3 | GO:0035121 | obsolete tail morphogenesis(GO:0035121) |
0.1 | 0.3 | GO:0030252 | growth hormone secretion(GO:0030252) |
0.1 | 0.2 | GO:0018119 | protein nitrosylation(GO:0017014) peptidyl-cysteine S-nitrosylation(GO:0018119) |
0.1 | 5.2 | GO:0007218 | neuropeptide signaling pathway(GO:0007218) |
0.1 | 0.6 | GO:0007340 | acrosome reaction(GO:0007340) |
0.1 | 0.5 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.1 | 0.1 | GO:0060056 | mammary gland involution(GO:0060056) |
0.1 | 0.6 | GO:0060415 | muscle tissue morphogenesis(GO:0060415) |
0.1 | 0.2 | GO:0044065 | regulation of respiratory system process(GO:0044065) |
0.1 | 0.2 | GO:0070207 | protein homotrimerization(GO:0070207) |
0.1 | 0.2 | GO:0010155 | regulation of proton transport(GO:0010155) |
0.1 | 0.1 | GO:0045821 | positive regulation of nucleotide catabolic process(GO:0030813) positive regulation of glycolytic process(GO:0045821) positive regulation of nucleoside metabolic process(GO:0045979) positive regulation of cofactor metabolic process(GO:0051194) positive regulation of coenzyme metabolic process(GO:0051197) positive regulation of ATP metabolic process(GO:1903580) |
0.1 | 0.6 | GO:0007492 | endoderm development(GO:0007492) |
0.1 | 8.5 | GO:0006813 | potassium ion transport(GO:0006813) |
0.1 | 0.3 | GO:0007210 | serotonin receptor signaling pathway(GO:0007210) |
0.1 | 0.7 | GO:0030510 | regulation of BMP signaling pathway(GO:0030510) |
0.1 | 0.1 | GO:0071688 | skeletal muscle myosin thick filament assembly(GO:0030241) myosin filament organization(GO:0031033) myosin filament assembly(GO:0031034) striated muscle myosin thick filament assembly(GO:0071688) |
0.1 | 0.4 | GO:0007530 | sex determination(GO:0007530) |
0.1 | 0.2 | GO:0016264 | gap junction assembly(GO:0016264) |
0.1 | 0.1 | GO:0061101 | neuroendocrine cell differentiation(GO:0061101) |
0.1 | 0.3 | GO:0030259 | lipid glycosylation(GO:0030259) |
0.1 | 0.8 | GO:0010828 | positive regulation of glucose transport(GO:0010828) |
0.1 | 0.8 | GO:0072163 | ureteric bud development(GO:0001657) mesonephric epithelium development(GO:0072163) mesonephric tubule development(GO:0072164) |
0.1 | 0.3 | GO:0051703 | social behavior(GO:0035176) intraspecies interaction between organisms(GO:0051703) |
0.1 | 0.2 | GO:0046952 | ketone body catabolic process(GO:0046952) |
0.1 | 1.6 | GO:0048066 | developmental pigmentation(GO:0048066) |
0.1 | 0.1 | GO:0055009 | atrial cardiac muscle tissue development(GO:0003228) atrial cardiac muscle tissue morphogenesis(GO:0055009) |
0.1 | 0.1 | GO:0043691 | reverse cholesterol transport(GO:0043691) |
0.1 | 0.3 | GO:0007130 | synaptonemal complex assembly(GO:0007130) |
0.1 | 0.4 | GO:0043392 | negative regulation of DNA binding(GO:0043392) |
0.1 | 0.2 | GO:0006296 | nucleotide-excision repair, DNA incision, 5'-to lesion(GO:0006296) |
0.1 | 0.1 | GO:0048645 | organ formation(GO:0048645) |
0.1 | 0.1 | GO:0060045 | positive regulation of cardiac muscle tissue growth(GO:0055023) positive regulation of cardiac muscle tissue development(GO:0055025) positive regulation of cardiac muscle cell proliferation(GO:0060045) positive regulation of heart growth(GO:0060421) |
0.1 | 0.4 | GO:0007512 | adult heart development(GO:0007512) |
0.1 | 0.1 | GO:0033083 | regulation of immature T cell proliferation(GO:0033083) |
0.1 | 0.5 | GO:0006704 | glucocorticoid biosynthetic process(GO:0006704) |
0.1 | 0.3 | GO:0055003 | cardiac myofibril assembly(GO:0055003) |
0.1 | 0.1 | GO:0015812 | gamma-aminobutyric acid transport(GO:0015812) |
0.1 | 0.1 | GO:0060999 | positive regulation of dendritic spine development(GO:0060999) |
0.1 | 0.3 | GO:0006002 | fructose 6-phosphate metabolic process(GO:0006002) |
0.1 | 0.1 | GO:0032276 | regulation of gonadotropin secretion(GO:0032276) |
0.1 | 0.2 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
0.1 | 0.4 | GO:0032456 | endocytic recycling(GO:0032456) |
0.1 | 0.1 | GO:0051926 | negative regulation of calcium ion transport(GO:0051926) |
0.1 | 0.6 | GO:0006182 | cGMP biosynthetic process(GO:0006182) |
0.1 | 0.4 | GO:0045806 | negative regulation of endocytosis(GO:0045806) |
0.1 | 0.2 | GO:0007431 | salivary gland development(GO:0007431) |
0.1 | 0.3 | GO:0043616 | keratinocyte proliferation(GO:0043616) |
0.1 | 0.1 | GO:0006907 | pinocytosis(GO:0006907) |
0.1 | 0.3 | GO:0035272 | exocrine system development(GO:0035272) |
0.1 | 0.3 | GO:0009223 | pyrimidine deoxyribonucleotide catabolic process(GO:0009223) |
0.1 | 0.2 | GO:0060236 | regulation of mitotic spindle organization(GO:0060236) |
0.1 | 0.1 | GO:0065005 | protein-lipid complex assembly(GO:0065005) |
0.1 | 0.6 | GO:0007339 | binding of sperm to zona pellucida(GO:0007339) |
0.1 | 0.3 | GO:0048839 | inner ear development(GO:0048839) |
0.0 | 1.3 | GO:0007588 | excretion(GO:0007588) |
0.0 | 0.3 | GO:0001709 | cell fate determination(GO:0001709) |
0.0 | 0.1 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
0.0 | 0.1 | GO:0014888 | striated muscle adaptation(GO:0014888) |
0.0 | 0.1 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
0.0 | 0.1 | GO:0015816 | glycine transport(GO:0015816) |
0.0 | 0.1 | GO:0050922 | negative regulation of chemotaxis(GO:0050922) |
0.0 | 0.2 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.0 | 0.1 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
0.0 | 0.1 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
0.0 | 0.8 | GO:0001539 | cilium or flagellum-dependent cell motility(GO:0001539) |
0.0 | 0.1 | GO:0008354 | germ cell migration(GO:0008354) |
0.0 | 0.0 | GO:0007184 | SMAD protein import into nucleus(GO:0007184) |
0.0 | 0.1 | GO:1903312 | negative regulation of mRNA processing(GO:0050686) negative regulation of mRNA metabolic process(GO:1903312) |
0.0 | 0.1 | GO:1903792 | negative regulation of anion transport(GO:1903792) |
0.0 | 0.2 | GO:0019852 | L-ascorbic acid metabolic process(GO:0019852) |
0.0 | 0.2 | GO:0043276 | anoikis(GO:0043276) |
0.0 | 0.9 | GO:0051216 | cartilage development(GO:0051216) |
0.0 | 0.8 | GO:0007193 | adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway(GO:0007193) |
0.0 | 0.1 | GO:0009128 | nucleoside monophosphate catabolic process(GO:0009125) purine nucleoside monophosphate catabolic process(GO:0009128) ribonucleoside monophosphate catabolic process(GO:0009158) purine ribonucleoside monophosphate catabolic process(GO:0009169) |
0.0 | 0.0 | GO:0010002 | cardioblast differentiation(GO:0010002) |
0.0 | 0.1 | GO:0051482 | positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway(GO:0051482) |
0.0 | 0.0 | GO:0042693 | muscle cell fate commitment(GO:0042693) |
0.0 | 1.1 | GO:0046546 | male gonad development(GO:0008584) development of primary male sexual characteristics(GO:0046546) |
0.0 | 10.8 | GO:0007409 | axonogenesis(GO:0007409) |
0.0 | 0.1 | GO:0008343 | adult feeding behavior(GO:0008343) |
0.0 | 0.1 | GO:0048484 | enteric nervous system development(GO:0048484) |
0.0 | 0.4 | GO:0006707 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
0.0 | 0.1 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
0.0 | 0.2 | GO:0009650 | UV protection(GO:0009650) |
0.0 | 0.6 | GO:0009584 | detection of visible light(GO:0009584) |
0.0 | 0.1 | GO:0045742 | positive regulation of epidermal growth factor receptor signaling pathway(GO:0045742) positive regulation of ERBB signaling pathway(GO:1901186) |
0.0 | 1.1 | GO:0008543 | fibroblast growth factor receptor signaling pathway(GO:0008543) |
0.0 | 0.0 | GO:0046476 | glycosylceramide biosynthetic process(GO:0046476) |
0.0 | 0.1 | GO:0009188 | ADP biosynthetic process(GO:0006172) purine nucleoside diphosphate biosynthetic process(GO:0009136) purine ribonucleoside diphosphate biosynthetic process(GO:0009180) ribonucleoside diphosphate biosynthetic process(GO:0009188) |
0.0 | 0.3 | GO:0015671 | oxygen transport(GO:0015671) |
0.0 | 0.0 | GO:0030878 | thyroid gland development(GO:0030878) |
0.0 | 0.2 | GO:0031848 | protection from non-homologous end joining at telomere(GO:0031848) telomere maintenance in response to DNA damage(GO:0043247) |
0.0 | 0.2 | GO:0018101 | citrulline metabolic process(GO:0000052) protein citrullination(GO:0018101) citrulline biosynthetic process(GO:0019240) |
0.0 | 0.1 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.0 | 0.4 | GO:0007566 | embryo implantation(GO:0007566) |
0.0 | 0.6 | GO:0030574 | collagen catabolic process(GO:0030574) |
0.0 | 0.3 | GO:0048813 | dendrite morphogenesis(GO:0048813) |
0.0 | 0.3 | GO:0006108 | malate metabolic process(GO:0006108) |
0.0 | 0.1 | GO:0002090 | regulation of receptor internalization(GO:0002090) |
0.0 | 0.3 | GO:0042572 | retinol metabolic process(GO:0042572) |
0.0 | 0.0 | GO:0044320 | cellular response to leptin stimulus(GO:0044320) response to leptin(GO:0044321) |
0.0 | 0.1 | GO:0071548 | response to dexamethasone(GO:0071548) |
0.0 | 0.3 | GO:0046498 | S-adenosylhomocysteine metabolic process(GO:0046498) |
0.0 | 0.1 | GO:0045793 | positive regulation of cell size(GO:0045793) |
0.0 | 0.3 | GO:0007141 | male meiosis I(GO:0007141) |
0.0 | 0.1 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
0.0 | 0.0 | GO:0006930 | substrate-dependent cell migration, cell extension(GO:0006930) |
0.0 | 0.3 | GO:0033144 | negative regulation of intracellular steroid hormone receptor signaling pathway(GO:0033144) |
0.0 | 0.3 | GO:0051567 | histone H3-K9 methylation(GO:0051567) histone H3-K9 modification(GO:0061647) |
0.0 | 0.2 | GO:0031280 | negative regulation of adenylate cyclase activity(GO:0007194) negative regulation of cyclase activity(GO:0031280) negative regulation of lyase activity(GO:0051350) |
0.0 | 0.1 | GO:0034214 | protein hexamerization(GO:0034214) |
0.0 | 0.1 | GO:0016999 | antibiotic metabolic process(GO:0016999) antibiotic biosynthetic process(GO:0017000) |
0.0 | 0.4 | GO:0033344 | cholesterol efflux(GO:0033344) |
0.0 | 0.3 | GO:0043462 | regulation of ATPase activity(GO:0043462) |
0.0 | 0.4 | GO:0071577 | zinc II ion transmembrane transport(GO:0071577) |
0.0 | 0.2 | GO:0018106 | peptidyl-histidine phosphorylation(GO:0018106) |
0.0 | 0.1 | GO:0048245 | eosinophil chemotaxis(GO:0048245) eosinophil migration(GO:0072677) |
0.0 | 0.3 | GO:0050766 | positive regulation of phagocytosis(GO:0050766) |
0.0 | 0.2 | GO:0034394 | protein localization to cell surface(GO:0034394) |
0.0 | 0.1 | GO:0051973 | positive regulation of telomerase activity(GO:0051973) |
0.0 | 0.1 | GO:0006531 | aspartate metabolic process(GO:0006531) aspartate catabolic process(GO:0006533) |
0.0 | 0.1 | GO:0030488 | tRNA methylation(GO:0030488) |
0.0 | 0.1 | GO:0015889 | cobalamin transport(GO:0015889) |
0.0 | 0.1 | GO:0090292 | nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
0.0 | 0.0 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
0.0 | 0.0 | GO:0048625 | myoblast fate commitment(GO:0048625) |
0.0 | 0.3 | GO:0031345 | negative regulation of cell projection organization(GO:0031345) |
0.0 | 0.3 | GO:0007212 | dopamine receptor signaling pathway(GO:0007212) |
0.0 | 0.1 | GO:0046618 | drug export(GO:0046618) |
0.0 | 0.1 | GO:0042178 | xenobiotic catabolic process(GO:0042178) |
0.0 | 0.6 | GO:0030178 | negative regulation of Wnt signaling pathway(GO:0030178) |
0.0 | 0.1 | GO:0014046 | dopamine secretion(GO:0014046) regulation of dopamine secretion(GO:0014059) |
0.0 | 0.1 | GO:0007622 | rhythmic behavior(GO:0007622) circadian behavior(GO:0048512) |
0.0 | 0.0 | GO:0001831 | trophectodermal cellular morphogenesis(GO:0001831) |
0.0 | 0.2 | GO:0048705 | skeletal system morphogenesis(GO:0048705) |
0.0 | 0.1 | GO:0048003 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) |
0.0 | 0.0 | GO:0019532 | oxalate transport(GO:0019532) |
0.0 | 0.1 | GO:0019695 | choline metabolic process(GO:0019695) |
0.0 | 0.1 | GO:0043536 | positive regulation of blood vessel endothelial cell migration(GO:0043536) |
0.0 | 0.0 | GO:0061318 | renal filtration cell differentiation(GO:0061318) glomerular epithelium development(GO:0072010) glomerular visceral epithelial cell differentiation(GO:0072112) glomerular epithelial cell differentiation(GO:0072311) |
0.0 | 0.0 | GO:0042415 | norepinephrine metabolic process(GO:0042415) |
0.0 | 0.1 | GO:0006590 | thyroid hormone generation(GO:0006590) |
0.0 | 0.0 | GO:0060749 | mammary gland alveolus development(GO:0060749) mammary gland lobule development(GO:0061377) |
0.0 | 0.1 | GO:0032933 | SREBP signaling pathway(GO:0032933) cellular response to sterol depletion(GO:0071501) |
0.0 | 0.1 | GO:0000422 | mitophagy(GO:0000422) mitochondrion disassembly(GO:0061726) |
0.0 | 0.7 | GO:0043407 | negative regulation of MAP kinase activity(GO:0043407) |
0.0 | 0.3 | GO:0008272 | sulfate transport(GO:0008272) |
0.0 | 0.0 | GO:0060575 | intestinal epithelial cell differentiation(GO:0060575) |
0.0 | 0.2 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
0.0 | 0.4 | GO:0042744 | hydrogen peroxide catabolic process(GO:0042744) |
0.0 | 0.2 | GO:0000266 | mitochondrial fission(GO:0000266) |
0.0 | 0.2 | GO:0051205 | protein insertion into membrane(GO:0051205) |
0.0 | 0.1 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) protein side chain deglutamylation(GO:0035610) |
0.0 | 0.1 | GO:0019731 | antibacterial humoral response(GO:0019731) |
0.0 | 0.1 | GO:0030865 | cortical cytoskeleton organization(GO:0030865) cortical actin cytoskeleton organization(GO:0030866) |
0.0 | 0.0 | GO:1901998 | antibiotic transport(GO:0042891) toxin transport(GO:1901998) |
0.0 | 0.4 | GO:0042472 | inner ear morphogenesis(GO:0042472) |
0.0 | 0.2 | GO:0070374 | positive regulation of ERK1 and ERK2 cascade(GO:0070374) |
0.0 | 0.0 | GO:0045650 | negative regulation of macrophage differentiation(GO:0045650) |
0.0 | 0.0 | GO:0071470 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum(GO:0010880) release of sequestered calcium ion into cytosol by sarcoplasmic reticulum(GO:0014808) cellular response to osmotic stress(GO:0071470) calcium ion transport from endoplasmic reticulum to cytosol(GO:1903514) |
0.0 | 0.2 | GO:0048009 | insulin-like growth factor receptor signaling pathway(GO:0048009) |
0.0 | 0.2 | GO:0019433 | triglyceride catabolic process(GO:0019433) |
0.0 | 0.0 | GO:0045723 | positive regulation of fatty acid biosynthetic process(GO:0045723) |
0.0 | 0.1 | GO:0033962 | cytoplasmic mRNA processing body assembly(GO:0033962) |
0.0 | 0.0 | GO:0002326 | B cell lineage commitment(GO:0002326) |
0.0 | 0.1 | GO:0036473 | intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0008631) cell death in response to oxidative stress(GO:0036473) |
0.0 | 0.1 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
0.0 | 0.0 | GO:0009129 | UMP biosynthetic process(GO:0006222) pyrimidine nucleoside monophosphate metabolic process(GO:0009129) pyrimidine ribonucleoside monophosphate metabolic process(GO:0009173) pyrimidine ribonucleoside monophosphate biosynthetic process(GO:0009174) UMP metabolic process(GO:0046049) |
0.0 | 0.1 | GO:0006477 | protein sulfation(GO:0006477) |
0.0 | 0.0 | GO:0007132 | meiotic metaphase I(GO:0007132) |
0.0 | 0.1 | GO:0000103 | sulfate assimilation(GO:0000103) |
0.0 | 0.4 | GO:0030216 | keratinocyte differentiation(GO:0030216) |
0.0 | 0.0 | GO:0060996 | dendritic spine development(GO:0060996) |
0.0 | 0.0 | GO:0060014 | granulosa cell differentiation(GO:0060014) |
0.0 | 0.0 | GO:0006855 | drug transmembrane transport(GO:0006855) |
0.0 | 0.0 | GO:0009296 | obsolete flagellum assembly(GO:0009296) |
0.0 | 0.1 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.0 | 0.1 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.0 | 1.2 | GO:0035023 | regulation of Rho protein signal transduction(GO:0035023) |
0.0 | 0.1 | GO:0072501 | cellular phosphate ion homeostasis(GO:0030643) cellular divalent inorganic anion homeostasis(GO:0072501) cellular trivalent inorganic anion homeostasis(GO:0072502) |
0.0 | 0.2 | GO:0001578 | microtubule bundle formation(GO:0001578) |
0.0 | 0.0 | GO:0032109 | positive regulation of response to extracellular stimulus(GO:0032106) positive regulation of response to nutrient levels(GO:0032109) |
0.0 | 0.0 | GO:0003032 | detection of oxygen(GO:0003032) |
0.0 | 0.3 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.0 | 0.1 | GO:0002857 | natural killer cell mediated cytotoxicity directed against tumor cell target(GO:0002420) natural killer cell mediated immune response to tumor cell(GO:0002423) regulation of natural killer cell mediated immune response to tumor cell(GO:0002855) positive regulation of natural killer cell mediated immune response to tumor cell(GO:0002857) regulation of natural killer cell mediated cytotoxicity directed against tumor cell target(GO:0002858) positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target(GO:0002860) |
0.0 | 0.1 | GO:0045668 | negative regulation of osteoblast differentiation(GO:0045668) |
0.0 | 0.0 | GO:0002220 | innate immune response activating cell surface receptor signaling pathway(GO:0002220) |
0.0 | 0.0 | GO:0051182 | coenzyme transport(GO:0051182) |
0.0 | 0.0 | GO:0034244 | negative regulation of DNA-templated transcription, elongation(GO:0032785) negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
0.0 | 0.0 | GO:0000212 | meiotic spindle organization(GO:0000212) |
0.0 | 0.8 | GO:0008544 | epidermis development(GO:0008544) |
0.0 | 0.0 | GO:0010677 | negative regulation of cellular carbohydrate metabolic process(GO:0010677) |
0.0 | 0.0 | GO:0014904 | myotube cell development(GO:0014904) skeletal muscle fiber development(GO:0048741) |
0.0 | 0.0 | GO:0048569 | post-embryonic organ development(GO:0048569) |
0.0 | 0.3 | GO:0016998 | cell wall macromolecule catabolic process(GO:0016998) |
0.0 | 0.1 | GO:0015695 | organic cation transport(GO:0015695) |
0.0 | 0.0 | GO:0051938 | L-glutamate import(GO:0051938) |
0.0 | 0.1 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
0.0 | 0.0 | GO:0032634 | interleukin-5 production(GO:0032634) regulation of interleukin-5 production(GO:0032674) |
0.0 | 0.1 | GO:0031532 | actin cytoskeleton reorganization(GO:0031532) |
0.0 | 0.1 | GO:0032069 | regulation of nuclease activity(GO:0032069) |
0.0 | 0.1 | GO:0098764 | meiosis I cell cycle phase(GO:0098764) |
0.0 | 0.0 | GO:0010159 | specification of organ position(GO:0010159) |
0.0 | 0.1 | GO:0002888 | positive regulation of myeloid leukocyte mediated immunity(GO:0002888) |
0.0 | 0.0 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
0.0 | 0.1 | GO:0034199 | activation of protein kinase A activity(GO:0034199) |
0.0 | 0.1 | GO:0048286 | lung alveolus development(GO:0048286) |
0.0 | 0.0 | GO:0046037 | GMP metabolic process(GO:0046037) |
0.0 | 0.1 | GO:0051149 | positive regulation of muscle cell differentiation(GO:0051149) |
0.0 | 0.1 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.0 | 0.0 | GO:0036230 | granulocyte activation(GO:0036230) neutrophil activation(GO:0042119) |
0.0 | 0.1 | GO:0001516 | prostaglandin biosynthetic process(GO:0001516) prostanoid biosynthetic process(GO:0046457) |
0.0 | 0.1 | GO:0042246 | tissue regeneration(GO:0042246) |
0.0 | 0.0 | GO:0045905 | translational frameshifting(GO:0006452) positive regulation of translational elongation(GO:0045901) positive regulation of translational termination(GO:0045905) |
0.0 | 0.0 | GO:0000491 | small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
0.0 | 0.1 | GO:0019184 | nonribosomal peptide biosynthetic process(GO:0019184) |
0.0 | 0.0 | GO:0019430 | removal of superoxide radicals(GO:0019430) cellular response to oxygen radical(GO:0071450) cellular response to superoxide(GO:0071451) cellular oxidant detoxification(GO:0098869) cellular detoxification(GO:1990748) |
0.0 | 0.1 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.0 | 0.0 | GO:0008210 | estrogen metabolic process(GO:0008210) |
0.0 | 0.0 | GO:0006548 | histidine catabolic process(GO:0006548) imidazole-containing compound catabolic process(GO:0052805) |
0.0 | 0.0 | GO:0003309 | type B pancreatic cell differentiation(GO:0003309) |
0.0 | 0.0 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.0 | 0.1 | GO:0015074 | DNA integration(GO:0015074) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.7 | 2.2 | GO:0032449 | CBM complex(GO:0032449) |
0.7 | 2.0 | GO:0030934 | anchoring collagen complex(GO:0030934) |
0.7 | 0.7 | GO:0005900 | oncostatin-M receptor complex(GO:0005900) |
0.6 | 2.9 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.6 | 4.0 | GO:0005606 | laminin-1 complex(GO:0005606) |
0.5 | 1.6 | GO:0098647 | collagen type VI trimer(GO:0005589) collagen beaded filament(GO:0098647) |
0.5 | 1.6 | GO:0043083 | synaptic cleft(GO:0043083) |
0.5 | 0.5 | GO:0043260 | laminin-11 complex(GO:0043260) |
0.5 | 3.3 | GO:0098642 | network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) |
0.4 | 2.7 | GO:0010369 | chromocenter(GO:0010369) |
0.4 | 1.6 | GO:0005593 | FACIT collagen trimer(GO:0005593) |
0.4 | 1.1 | GO:0005588 | collagen type V trimer(GO:0005588) |
0.3 | 2.1 | GO:0001527 | microfibril(GO:0001527) |
0.3 | 1.2 | GO:0030056 | hemidesmosome(GO:0030056) |
0.3 | 0.9 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.3 | 3.0 | GO:0031941 | filamentous actin(GO:0031941) |
0.3 | 0.8 | GO:0070852 | cell body fiber(GO:0070852) |
0.3 | 1.0 | GO:0005915 | zonula adherens(GO:0005915) |
0.2 | 4.9 | GO:0030057 | desmosome(GO:0030057) |
0.2 | 3.9 | GO:0005581 | collagen trimer(GO:0005581) |
0.2 | 0.7 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
0.2 | 3.1 | GO:0005858 | axonemal dynein complex(GO:0005858) |
0.2 | 1.2 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
0.2 | 0.9 | GO:0030673 | axolemma(GO:0030673) |
0.2 | 0.4 | GO:0044447 | axoneme part(GO:0044447) |
0.2 | 0.8 | GO:0031045 | dense core granule(GO:0031045) |
0.2 | 0.6 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.2 | 1.6 | GO:0005614 | interstitial matrix(GO:0005614) |
0.2 | 0.2 | GO:0031527 | filopodium membrane(GO:0031527) |
0.2 | 2.3 | GO:0031528 | microvillus membrane(GO:0031528) |
0.2 | 2.1 | GO:0030315 | T-tubule(GO:0030315) |
0.2 | 4.1 | GO:0005796 | Golgi lumen(GO:0005796) |
0.2 | 2.4 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.2 | 0.7 | GO:0016342 | catenin complex(GO:0016342) |
0.2 | 0.9 | GO:0071437 | invadopodium(GO:0071437) |
0.2 | 0.7 | GO:0043218 | compact myelin(GO:0043218) |
0.2 | 0.3 | GO:0002139 | stereocilia coupling link(GO:0002139) stereocilia ankle link(GO:0002141) stereocilia ankle link complex(GO:0002142) |
0.2 | 40.9 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
0.2 | 0.2 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.2 | 1.3 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.2 | 8.1 | GO:0031012 | extracellular matrix(GO:0031012) |
0.2 | 0.3 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.2 | 0.9 | GO:0016011 | dystroglycan complex(GO:0016011) sarcoglycan complex(GO:0016012) |
0.2 | 0.2 | GO:0012510 | trans-Golgi network transport vesicle membrane(GO:0012510) |
0.1 | 0.6 | GO:0033268 | node of Ranvier(GO:0033268) |
0.1 | 0.6 | GO:0016942 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) |
0.1 | 1.4 | GO:0043034 | costamere(GO:0043034) |
0.1 | 0.4 | GO:0045323 | interleukin-1 receptor complex(GO:0045323) |
0.1 | 0.3 | GO:0044291 | intercalated disc(GO:0014704) cell-cell contact zone(GO:0044291) |
0.1 | 2.2 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
0.1 | 0.4 | GO:0033270 | paranode region of axon(GO:0033270) |
0.1 | 1.5 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.1 | 0.5 | GO:0031512 | motile primary cilium(GO:0031512) |
0.1 | 10.5 | GO:0005925 | focal adhesion(GO:0005925) |
0.1 | 0.1 | GO:0071664 | catenin-TCF7L2 complex(GO:0071664) |
0.1 | 9.3 | GO:0014069 | postsynaptic density(GO:0014069) postsynaptic specialization(GO:0099572) |
0.1 | 0.3 | GO:0032806 | carboxy-terminal domain protein kinase complex(GO:0032806) |
0.1 | 6.1 | GO:0030426 | growth cone(GO:0030426) |
0.1 | 2.2 | GO:0005912 | adherens junction(GO:0005912) |
0.1 | 0.3 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.1 | 0.5 | GO:0071546 | pi-body(GO:0071546) |
0.1 | 0.5 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.1 | 0.4 | GO:0005862 | muscle thin filament tropomyosin(GO:0005862) |
0.1 | 5.7 | GO:0070160 | bicellular tight junction(GO:0005923) occluding junction(GO:0070160) |
0.1 | 7.6 | GO:0034705 | voltage-gated potassium channel complex(GO:0008076) potassium channel complex(GO:0034705) |
0.1 | 0.4 | GO:0000801 | central element(GO:0000801) |
0.1 | 0.4 | GO:0033018 | sarcoplasmic reticulum lumen(GO:0033018) |
0.1 | 4.4 | GO:0005911 | cell-cell junction(GO:0005911) |
0.1 | 0.4 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.1 | 0.2 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.1 | 0.4 | GO:0005652 | nuclear lamina(GO:0005652) |
0.1 | 0.3 | GO:0042599 | lamellar body(GO:0042599) |
0.1 | 0.3 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.1 | 0.1 | GO:0098878 | ionotropic glutamate receptor complex(GO:0008328) neurotransmitter receptor complex(GO:0098878) |
0.1 | 1.6 | GO:0043679 | axon terminus(GO:0043679) |
0.1 | 7.1 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.1 | 0.4 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.1 | 0.4 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.1 | 1.7 | GO:0031093 | platelet alpha granule lumen(GO:0031093) |
0.1 | 0.2 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.1 | 1.2 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
0.1 | 13.9 | GO:0005667 | transcription factor complex(GO:0005667) |
0.1 | 0.1 | GO:0043159 | acrosomal matrix(GO:0043159) |
0.1 | 0.3 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.1 | 0.1 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
0.1 | 0.2 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
0.1 | 0.3 | GO:0030128 | AP-2 adaptor complex(GO:0030122) clathrin coat of endocytic vesicle(GO:0030128) |
0.1 | 0.2 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.0 | 0.5 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
0.0 | 0.8 | GO:0019861 | obsolete flagellum(GO:0019861) |
0.0 | 0.2 | GO:0031091 | platelet alpha granule(GO:0031091) |
0.0 | 3.1 | GO:0008021 | synaptic vesicle(GO:0008021) |
0.0 | 2.4 | GO:0034707 | chloride channel complex(GO:0034707) |
0.0 | 0.3 | GO:0090665 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
0.0 | 0.2 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.0 | 0.1 | GO:0001950 | obsolete plasma membrane enriched fraction(GO:0001950) |
0.0 | 24.2 | GO:0044421 | extracellular region part(GO:0044421) |
0.0 | 0.2 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
0.0 | 0.2 | GO:0000805 | X chromosome(GO:0000805) |
0.0 | 0.1 | GO:0034706 | sodium channel complex(GO:0034706) |
0.0 | 0.3 | GO:0045211 | postsynaptic membrane(GO:0045211) |
0.0 | 0.6 | GO:0016460 | myosin II complex(GO:0016460) |
0.0 | 2.0 | GO:0044449 | contractile fiber part(GO:0044449) |
0.0 | 0.1 | GO:0071547 | piP-body(GO:0071547) |
0.0 | 0.2 | GO:0045261 | proton-transporting ATP synthase complex, catalytic core F(1)(GO:0045261) |
0.0 | 0.1 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
0.0 | 0.3 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.0 | 0.4 | GO:0005833 | hemoglobin complex(GO:0005833) |
0.0 | 0.5 | GO:0005811 | lipid particle(GO:0005811) |
0.0 | 0.2 | GO:0033162 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.0 | 0.3 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.0 | 1.3 | GO:0001726 | ruffle(GO:0001726) |
0.0 | 1.9 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.0 | 2.9 | GO:0030054 | cell junction(GO:0030054) |
0.0 | 0.2 | GO:0032589 | neuron projection membrane(GO:0032589) |
0.0 | 23.3 | GO:0005576 | extracellular region(GO:0005576) |
0.0 | 1.3 | GO:0030425 | dendrite(GO:0030425) |
0.0 | 0.0 | GO:0031983 | vesicle lumen(GO:0031983) |
0.0 | 0.1 | GO:0001739 | sex chromatin(GO:0001739) |
0.0 | 2.1 | GO:0045095 | keratin filament(GO:0045095) |
0.0 | 0.2 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.0 | 0.1 | GO:0031307 | integral component of mitochondrial outer membrane(GO:0031307) |
0.0 | 1.6 | GO:0005882 | intermediate filament(GO:0005882) |
0.0 | 0.1 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.0 | 0.1 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
0.0 | 13.7 | GO:0005887 | integral component of plasma membrane(GO:0005887) |
0.0 | 0.1 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.0 | 0.0 | GO:0018995 | host(GO:0018995) host cell part(GO:0033643) host intracellular part(GO:0033646) intracellular region of host(GO:0043656) host cell(GO:0043657) other organism(GO:0044215) other organism cell(GO:0044216) other organism part(GO:0044217) |
0.0 | 0.1 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) respiratory chain complex IV(GO:0045277) |
0.0 | 0.1 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.0 | 0.4 | GO:0030136 | clathrin-coated vesicle(GO:0030136) |
0.0 | 0.2 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
0.0 | 0.4 | GO:0030118 | clathrin coat(GO:0030118) |
0.0 | 0.1 | GO:0005655 | nucleolar ribonuclease P complex(GO:0005655) ribonuclease P complex(GO:0030677) multimeric ribonuclease P complex(GO:0030681) |
0.0 | 0.0 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.0 | 3.1 | GO:0005017 | platelet-derived growth factor-activated receptor activity(GO:0005017) |
0.7 | 2.6 | GO:0048495 | Roundabout binding(GO:0048495) |
0.6 | 3.8 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
0.6 | 0.6 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
0.6 | 2.3 | GO:0048018 | receptor agonist activity(GO:0048018) |
0.5 | 1.6 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
0.5 | 1.6 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.5 | 4.6 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.5 | 1.5 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
0.5 | 1.9 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
0.5 | 1.5 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.5 | 2.9 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.5 | 1.4 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.5 | 2.3 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
0.4 | 1.3 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
0.4 | 1.3 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.4 | 1.3 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.4 | 1.6 | GO:0004656 | procollagen-proline 4-dioxygenase activity(GO:0004656) peptidyl-proline 4-dioxygenase activity(GO:0031545) |
0.4 | 1.2 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
0.4 | 1.1 | GO:0004938 | alpha-adrenergic receptor activity(GO:0004936) alpha2-adrenergic receptor activity(GO:0004938) |
0.4 | 1.9 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.4 | 1.1 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.4 | 1.5 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.4 | 2.6 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) ubiquitin-like protein conjugating enzyme binding(GO:0044390) |
0.4 | 1.1 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
0.4 | 1.1 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.3 | 2.1 | GO:0005110 | frizzled-2 binding(GO:0005110) |
0.3 | 1.4 | GO:0005010 | insulin-like growth factor-activated receptor activity(GO:0005010) |
0.3 | 1.0 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.3 | 1.0 | GO:0003680 | AT DNA binding(GO:0003680) |
0.3 | 1.0 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.3 | 4.2 | GO:0005109 | frizzled binding(GO:0005109) |
0.3 | 1.3 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
0.3 | 0.9 | GO:0050698 | proteoglycan sulfotransferase activity(GO:0050698) |
0.3 | 5.0 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
0.3 | 2.0 | GO:0017166 | vinculin binding(GO:0017166) |
0.3 | 0.9 | GO:0004117 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) |
0.3 | 0.6 | GO:0043559 | insulin binding(GO:0043559) |
0.3 | 1.1 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.3 | 0.8 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.3 | 2.4 | GO:0043395 | heparan sulfate proteoglycan binding(GO:0043395) |
0.3 | 1.3 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.3 | 0.3 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.3 | 1.0 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.3 | 18.3 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.3 | 0.8 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.3 | 2.3 | GO:0015385 | sodium:proton antiporter activity(GO:0015385) |
0.3 | 1.5 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
0.2 | 1.0 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
0.2 | 4.2 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.2 | 0.9 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.2 | 0.9 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
0.2 | 0.7 | GO:0001601 | peptide YY receptor activity(GO:0001601) |
0.2 | 0.7 | GO:0008061 | chitin binding(GO:0008061) |
0.2 | 0.9 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.2 | 3.0 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
0.2 | 1.4 | GO:0005499 | vitamin D binding(GO:0005499) |
0.2 | 0.7 | GO:0000978 | RNA polymerase II core promoter proximal region sequence-specific DNA binding(GO:0000978) core promoter proximal region sequence-specific DNA binding(GO:0000987) core promoter proximal region DNA binding(GO:0001159) |
0.2 | 0.7 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.2 | 1.3 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
0.2 | 0.9 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
0.2 | 1.3 | GO:0042153 | obsolete RPTP-like protein binding(GO:0042153) |
0.2 | 0.9 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.2 | 0.4 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
0.2 | 0.6 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.2 | 1.2 | GO:0000982 | transcription factor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0000982) transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001077) transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001228) |
0.2 | 0.6 | GO:0050682 | AF-2 domain binding(GO:0050682) |
0.2 | 0.4 | GO:0045118 | azole transporter activity(GO:0045118) azole transmembrane transporter activity(GO:1901474) |
0.2 | 0.6 | GO:0003941 | L-serine ammonia-lyase activity(GO:0003941) |
0.2 | 2.7 | GO:0031490 | chromatin DNA binding(GO:0031490) |
0.2 | 1.3 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
0.2 | 0.9 | GO:0016717 | oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water(GO:0016717) |
0.2 | 0.9 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.2 | 0.6 | GO:0042910 | xenobiotic-transporting ATPase activity(GO:0008559) xenobiotic transporter activity(GO:0042910) |
0.2 | 1.3 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
0.2 | 0.5 | GO:0005346 | purine ribonucleotide transmembrane transporter activity(GO:0005346) |
0.2 | 3.4 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.2 | 0.4 | GO:0004935 | adrenergic receptor activity(GO:0004935) |
0.2 | 0.5 | GO:0070996 | type 1 melanocortin receptor binding(GO:0070996) |
0.2 | 1.6 | GO:0051378 | serotonin binding(GO:0051378) |
0.2 | 0.9 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.2 | 0.9 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.2 | 1.2 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.2 | 0.5 | GO:0004461 | lactose synthase activity(GO:0004461) |
0.2 | 0.5 | GO:0034584 | piRNA binding(GO:0034584) |
0.2 | 1.3 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.2 | 0.7 | GO:0016933 | extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
0.2 | 1.3 | GO:0030296 | protein tyrosine kinase activator activity(GO:0030296) |
0.2 | 0.5 | GO:0036137 | kynurenine-oxoglutarate transaminase activity(GO:0016212) kynurenine aminotransferase activity(GO:0036137) |
0.2 | 2.2 | GO:0030159 | receptor signaling complex scaffold activity(GO:0030159) |
0.2 | 1.1 | GO:0004630 | phospholipase D activity(GO:0004630) |
0.2 | 1.0 | GO:0043274 | phospholipase binding(GO:0043274) |
0.2 | 0.6 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.2 | 0.3 | GO:0043495 | protein anchor(GO:0043495) |
0.2 | 0.6 | GO:0005332 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) |
0.2 | 1.1 | GO:0003706 | obsolete ligand-regulated transcription factor activity(GO:0003706) |
0.2 | 0.3 | GO:0030955 | potassium ion binding(GO:0030955) |
0.2 | 2.3 | GO:0005227 | calcium activated cation channel activity(GO:0005227) |
0.2 | 0.5 | GO:0015137 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
0.2 | 0.3 | GO:0045545 | syndecan binding(GO:0045545) |
0.2 | 1.7 | GO:0034483 | heparan sulfate sulfotransferase activity(GO:0034483) |
0.2 | 2.9 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.2 | 0.5 | GO:0004465 | lipoprotein lipase activity(GO:0004465) |
0.1 | 3.0 | GO:0005242 | inward rectifier potassium channel activity(GO:0005242) |
0.1 | 0.4 | GO:0070052 | collagen V binding(GO:0070052) |
0.1 | 1.4 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.1 | 0.4 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.1 | 0.4 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
0.1 | 0.6 | GO:0031404 | chloride ion binding(GO:0031404) |
0.1 | 0.6 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
0.1 | 1.0 | GO:0030506 | ankyrin binding(GO:0030506) |
0.1 | 1.6 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.1 | 1.1 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
0.1 | 0.4 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
0.1 | 1.4 | GO:0030553 | cGMP binding(GO:0030553) |
0.1 | 0.1 | GO:0002162 | dystroglycan binding(GO:0002162) |
0.1 | 1.7 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.1 | 0.3 | GO:0070548 | L-glutamine aminotransferase activity(GO:0070548) |
0.1 | 0.8 | GO:0016290 | palmitoyl-CoA hydrolase activity(GO:0016290) |
0.1 | 0.8 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
0.1 | 1.0 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.1 | 0.6 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.1 | 0.1 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
0.1 | 0.4 | GO:0050544 | arachidonic acid binding(GO:0050544) |
0.1 | 0.4 | GO:0031705 | bombesin receptor binding(GO:0031705) endothelin B receptor binding(GO:0031708) |
0.1 | 1.2 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.1 | 6.3 | GO:0005178 | integrin binding(GO:0005178) |
0.1 | 0.6 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
0.1 | 1.1 | GO:0005112 | Notch binding(GO:0005112) |
0.1 | 0.6 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.1 | 0.6 | GO:0035240 | dopamine binding(GO:0035240) |
0.1 | 0.8 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.1 | 1.7 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.1 | 0.5 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.1 | 4.5 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.1 | 0.7 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.1 | 0.6 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
0.1 | 0.9 | GO:0015643 | toxic substance binding(GO:0015643) |
0.1 | 0.1 | GO:0048406 | nerve growth factor binding(GO:0048406) |
0.1 | 0.4 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.1 | 3.9 | GO:0004714 | transmembrane receptor protein tyrosine kinase activity(GO:0004714) |
0.1 | 0.3 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.1 | 3.1 | GO:0005272 | sodium channel activity(GO:0005272) |
0.1 | 0.3 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
0.1 | 0.7 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
0.1 | 0.3 | GO:0042978 | ornithine decarboxylase activator activity(GO:0042978) |
0.1 | 3.1 | GO:0050839 | cell adhesion molecule binding(GO:0050839) |
0.1 | 0.4 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
0.1 | 14.0 | GO:0008083 | growth factor activity(GO:0008083) |
0.1 | 0.1 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.1 | 0.4 | GO:0004157 | dihydropyrimidinase activity(GO:0004157) |
0.1 | 0.2 | GO:0031628 | opioid receptor binding(GO:0031628) |
0.1 | 0.6 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
0.1 | 0.3 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
0.1 | 2.4 | GO:0005518 | collagen binding(GO:0005518) |
0.1 | 0.4 | GO:0031685 | adenosine receptor binding(GO:0031685) |
0.1 | 0.4 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.1 | 0.3 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
0.1 | 0.3 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.1 | 0.4 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.1 | 1.8 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.1 | 1.6 | GO:0004970 | ionotropic glutamate receptor activity(GO:0004970) |
0.1 | 0.3 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.1 | 0.3 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.1 | 26.1 | GO:0030528 | obsolete transcription regulator activity(GO:0030528) |
0.1 | 0.4 | GO:0047429 | nucleoside-triphosphate diphosphatase activity(GO:0047429) |
0.1 | 3.4 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.1 | 0.5 | GO:0071855 | neuropeptide receptor binding(GO:0071855) |
0.1 | 0.7 | GO:0030371 | translation repressor activity(GO:0030371) |
0.1 | 0.4 | GO:0005497 | androgen binding(GO:0005497) |
0.1 | 0.3 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
0.1 | 0.1 | GO:0005451 | monovalent cation:proton antiporter activity(GO:0005451) |
0.1 | 0.4 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.1 | 0.2 | GO:0005113 | patched binding(GO:0005113) |
0.1 | 0.1 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
0.1 | 0.7 | GO:0050780 | dopamine receptor binding(GO:0050780) |
0.1 | 4.7 | GO:0008201 | heparin binding(GO:0008201) |
0.1 | 0.2 | GO:0071553 | uridine nucleotide receptor activity(GO:0015065) G-protein coupled pyrimidinergic nucleotide receptor activity(GO:0071553) |
0.1 | 0.2 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
0.1 | 1.3 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.1 | 0.9 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.1 | 0.2 | GO:0034617 | nitric-oxide synthase activity(GO:0004517) tetrahydrobiopterin binding(GO:0034617) |
0.1 | 0.2 | GO:0001012 | RNA polymerase II regulatory region sequence-specific DNA binding(GO:0000977) RNA polymerase II regulatory region DNA binding(GO:0001012) |
0.1 | 0.5 | GO:0008493 | tetracycline transporter activity(GO:0008493) |
0.1 | 0.2 | GO:0008107 | galactoside 2-alpha-L-fucosyltransferase activity(GO:0008107) alpha-(1,2)-fucosyltransferase activity(GO:0031127) |
0.1 | 0.6 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
0.1 | 0.7 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.1 | 0.5 | GO:0008469 | histone-arginine N-methyltransferase activity(GO:0008469) |
0.1 | 0.6 | GO:0008242 | omega peptidase activity(GO:0008242) |
0.1 | 0.2 | GO:0031702 | type 1 angiotensin receptor binding(GO:0031702) |
0.1 | 0.4 | GO:0016595 | glutamate binding(GO:0016595) |
0.1 | 0.2 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.1 | 0.4 | GO:0008504 | monoamine transmembrane transporter activity(GO:0008504) |
0.1 | 1.4 | GO:0004879 | RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding(GO:0004879) transcription factor activity, direct ligand regulated sequence-specific DNA binding(GO:0098531) |
0.1 | 0.4 | GO:0005355 | glucose transmembrane transporter activity(GO:0005355) |
0.1 | 1.4 | GO:0070405 | ammonium ion binding(GO:0070405) |
0.1 | 0.7 | GO:0019841 | retinol binding(GO:0019841) |
0.1 | 0.1 | GO:0052658 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) inositol-1,3,4,5-tetrakisphosphate 5-phosphatase activity(GO:0052659) |
0.1 | 1.2 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.1 | 0.9 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.1 | 0.2 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.1 | 0.3 | GO:0003960 | NADPH:quinone reductase activity(GO:0003960) |
0.1 | 0.2 | GO:0030151 | molybdenum ion binding(GO:0030151) |
0.1 | 0.4 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
0.1 | 1.3 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
0.1 | 0.3 | GO:0035255 | ionotropic glutamate receptor binding(GO:0035255) |
0.1 | 0.2 | GO:0004030 | aldehyde dehydrogenase [NAD(P)+] activity(GO:0004030) |
0.1 | 1.1 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
0.1 | 0.2 | GO:0035197 | siRNA binding(GO:0035197) |
0.1 | 6.1 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.1 | 0.2 | GO:0055077 | gap junction hemi-channel activity(GO:0055077) |
0.1 | 0.1 | GO:0035198 | miRNA binding(GO:0035198) |
0.1 | 0.2 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.1 | 0.3 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.1 | 0.7 | GO:0003711 | obsolete transcription elongation regulator activity(GO:0003711) |
0.1 | 0.6 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.1 | 0.6 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
0.1 | 0.1 | GO:0030247 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
0.1 | 0.8 | GO:0005328 | neurotransmitter:sodium symporter activity(GO:0005328) |
0.1 | 0.3 | GO:0004128 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) |
0.1 | 0.2 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.1 | 0.2 | GO:0005326 | neurotransmitter transporter activity(GO:0005326) |
0.1 | 0.3 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
0.1 | 0.2 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.1 | 0.3 | GO:0004022 | alcohol dehydrogenase (NAD) activity(GO:0004022) |
0.1 | 0.4 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.1 | 0.3 | GO:0016413 | O-acetyltransferase activity(GO:0016413) |
0.1 | 0.9 | GO:0015125 | bile acid transmembrane transporter activity(GO:0015125) |
0.1 | 4.3 | GO:0000981 | RNA polymerase II transcription factor activity, sequence-specific DNA binding(GO:0000981) |
0.1 | 0.2 | GO:0022897 | peptide:proton symporter activity(GO:0015333) proton-dependent peptide secondary active transmembrane transporter activity(GO:0022897) |
0.1 | 0.2 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.1 | 0.2 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.1 | 0.2 | GO:0030548 | acetylcholine receptor regulator activity(GO:0030548) neurotransmitter receptor regulator activity(GO:0099602) |
0.1 | 0.1 | GO:0000247 | C-8 sterol isomerase activity(GO:0000247) |
0.1 | 0.2 | GO:0000403 | Y-form DNA binding(GO:0000403) |
0.1 | 4.6 | GO:0005267 | potassium channel activity(GO:0005267) |
0.1 | 0.1 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
0.1 | 0.1 | GO:0070576 | vitamin D 24-hydroxylase activity(GO:0070576) |
0.1 | 1.1 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.1 | 1.5 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
0.1 | 0.5 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.1 | 0.2 | GO:0004466 | long-chain-acyl-CoA dehydrogenase activity(GO:0004466) |
0.1 | 0.2 | GO:0004470 | malic enzyme activity(GO:0004470) |
0.1 | 0.3 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
0.1 | 0.2 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.1 | 0.2 | GO:0070215 | obsolete MDM2 binding(GO:0070215) |
0.1 | 0.5 | GO:0008376 | acetylgalactosaminyltransferase activity(GO:0008376) |
0.1 | 1.0 | GO:0070330 | aromatase activity(GO:0070330) |
0.1 | 0.3 | GO:0034416 | bisphosphoglycerate phosphatase activity(GO:0034416) |
0.1 | 0.5 | GO:0009975 | cyclase activity(GO:0009975) |
0.1 | 0.3 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.0 | 0.9 | GO:0005158 | insulin receptor binding(GO:0005158) |
0.0 | 3.3 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.0 | 0.0 | GO:0005234 | extracellular-glutamate-gated ion channel activity(GO:0005234) |
0.0 | 0.1 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
0.0 | 0.5 | GO:0017046 | peptide hormone binding(GO:0017046) |
0.0 | 0.2 | GO:0016208 | AMP binding(GO:0016208) |
0.0 | 0.1 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) |
0.0 | 0.4 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.0 | 0.2 | GO:0004993 | G-protein coupled serotonin receptor activity(GO:0004993) serotonin receptor activity(GO:0099589) |
0.0 | 0.1 | GO:0016901 | oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
0.0 | 0.2 | GO:0019238 | cyclohydrolase activity(GO:0019238) |
0.0 | 0.2 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.0 | 3.2 | GO:0003777 | microtubule motor activity(GO:0003777) |
0.0 | 0.7 | GO:0004407 | histone deacetylase activity(GO:0004407) |
0.0 | 3.2 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.0 | 0.2 | GO:0030618 | transforming growth factor beta receptor, pathway-specific cytoplasmic mediator activity(GO:0030618) |
0.0 | 0.2 | GO:0001085 | RNA polymerase II transcription factor binding(GO:0001085) |
0.0 | 0.2 | GO:0080030 | methyl indole-3-acetate esterase activity(GO:0080030) methyl salicylate esterase activity(GO:0080031) methyl jasmonate esterase activity(GO:0080032) |
0.0 | 2.5 | GO:0005179 | hormone activity(GO:0005179) |
0.0 | 0.1 | GO:0016841 | ammonia-lyase activity(GO:0016841) |
0.0 | 0.1 | GO:0042806 | fucose binding(GO:0042806) |
0.0 | 0.4 | GO:0003840 | gamma-glutamyltransferase activity(GO:0003840) |
0.0 | 0.2 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
0.0 | 0.2 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.0 | 0.1 | GO:0051636 | obsolete Gram-negative bacterial cell surface binding(GO:0051636) |
0.0 | 0.1 | GO:0005314 | high-affinity glutamate transmembrane transporter activity(GO:0005314) |
0.0 | 0.2 | GO:0015057 | thrombin receptor activity(GO:0015057) |
0.0 | 0.1 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
0.0 | 0.2 | GO:0001848 | complement binding(GO:0001848) |
0.0 | 0.2 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
0.0 | 0.1 | GO:0015204 | urea transmembrane transporter activity(GO:0015204) |
0.0 | 0.1 | GO:0004103 | choline kinase activity(GO:0004103) |
0.0 | 0.1 | GO:0008900 | hydrogen:potassium-exchanging ATPase activity(GO:0008900) |
0.0 | 0.4 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.0 | 1.2 | GO:0042379 | chemokine receptor binding(GO:0042379) |
0.0 | 0.1 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.0 | 0.1 | GO:0004321 | fatty-acyl-CoA synthase activity(GO:0004321) |
0.0 | 0.1 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
0.0 | 0.2 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.0 | 0.2 | GO:0008172 | S-methyltransferase activity(GO:0008172) |
0.0 | 0.2 | GO:0000828 | inositol hexakisphosphate kinase activity(GO:0000828) inositol hexakisphosphate 5-kinase activity(GO:0000832) |
0.0 | 0.1 | GO:0004052 | arachidonate 12-lipoxygenase activity(GO:0004052) |
0.0 | 0.1 | GO:0034187 | obsolete apolipoprotein E binding(GO:0034187) |
0.0 | 3.5 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.0 | 0.1 | GO:0035014 | phosphatidylinositol 3-kinase regulator activity(GO:0035014) |
0.0 | 0.0 | GO:0031420 | alkali metal ion binding(GO:0031420) |
0.0 | 0.0 | GO:0016712 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen(GO:0016712) |
0.0 | 0.1 | GO:0043498 | obsolete cell surface binding(GO:0043498) |
0.0 | 0.1 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.0 | 0.3 | GO:0001619 | obsolete lysosphingolipid and lysophosphatidic acid receptor activity(GO:0001619) |
0.0 | 0.1 | GO:0019798 | procollagen-proline dioxygenase activity(GO:0019798) |
0.0 | 0.1 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
0.0 | 0.4 | GO:0005344 | oxygen transporter activity(GO:0005344) |
0.0 | 0.1 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
0.0 | 0.1 | GO:0001733 | galactosylceramide sulfotransferase activity(GO:0001733) galactose 3-O-sulfotransferase activity(GO:0050694) |
0.0 | 0.1 | GO:0042923 | neuropeptide binding(GO:0042923) |
0.0 | 0.6 | GO:0004364 | glutathione transferase activity(GO:0004364) |
0.0 | 0.2 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
0.0 | 0.2 | GO:0008171 | O-methyltransferase activity(GO:0008171) |
0.0 | 0.2 | GO:0008066 | glutamate receptor activity(GO:0008066) |
0.0 | 1.3 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.0 | 0.4 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.0 | 0.2 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
0.0 | 0.1 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.0 | 0.1 | GO:0004774 | succinate-CoA ligase activity(GO:0004774) |
0.0 | 0.2 | GO:0008271 | secondary active sulfate transmembrane transporter activity(GO:0008271) |
0.0 | 0.0 | GO:0051637 | obsolete Gram-positive bacterial cell surface binding(GO:0051637) |
0.0 | 0.2 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.0 | 0.1 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
0.0 | 0.1 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
0.0 | 0.3 | GO:0016917 | GABA receptor activity(GO:0016917) |
0.0 | 0.1 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.0 | 0.0 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
0.0 | 0.2 | GO:0003707 | steroid hormone receptor activity(GO:0003707) |
0.0 | 0.1 | GO:0004013 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.0 | 0.3 | GO:0035250 | UDP-galactosyltransferase activity(GO:0035250) |
0.0 | 0.2 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.0 | 0.1 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
0.0 | 0.2 | GO:0047760 | butyrate-CoA ligase activity(GO:0047760) |
0.0 | 0.1 | GO:0008106 | alcohol dehydrogenase (NADP+) activity(GO:0008106) |
0.0 | 0.1 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
0.0 | 0.1 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
0.0 | 0.1 | GO:0016454 | serine C-palmitoyltransferase activity(GO:0004758) C-palmitoyltransferase activity(GO:0016454) |
0.0 | 9.9 | GO:0005509 | calcium ion binding(GO:0005509) |
0.0 | 0.9 | GO:0051015 | actin filament binding(GO:0051015) |
0.0 | 0.1 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.0 | 0.1 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.0 | 0.1 | GO:0015301 | anion:anion antiporter activity(GO:0015301) |
0.0 | 0.1 | GO:0017060 | 3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase activity(GO:0017060) |
0.0 | 0.1 | GO:0004033 | aldo-keto reductase (NADP) activity(GO:0004033) |
0.0 | 0.3 | GO:0008236 | serine-type peptidase activity(GO:0008236) |
0.0 | 0.3 | GO:0032934 | sterol binding(GO:0032934) |
0.0 | 0.1 | GO:0004945 | angiotensin receptor activity(GO:0001595) angiotensin type II receptor activity(GO:0004945) |
0.0 | 0.0 | GO:0004977 | melanocortin receptor activity(GO:0004977) |
0.0 | 0.2 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.0 | 0.1 | GO:0032190 | acrosin binding(GO:0032190) |
0.0 | 1.1 | GO:0017124 | SH3 domain binding(GO:0017124) |
0.0 | 0.0 | GO:0051861 | glycolipid binding(GO:0051861) |
0.0 | 0.1 | GO:0003846 | 2-acylglycerol O-acyltransferase activity(GO:0003846) |
0.0 | 0.1 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
0.0 | 0.1 | GO:0008312 | 7S RNA binding(GO:0008312) |
0.0 | 0.0 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
0.0 | 0.1 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
0.0 | 0.1 | GO:0016847 | 1-aminocyclopropane-1-carboxylate synthase activity(GO:0016847) |
0.0 | 0.0 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
0.0 | 0.0 | GO:0001099 | basal transcription machinery binding(GO:0001098) basal RNA polymerase II transcription machinery binding(GO:0001099) |
0.0 | 0.4 | GO:0004497 | monooxygenase activity(GO:0004497) |
0.0 | 0.1 | GO:0019237 | centromeric DNA binding(GO:0019237) |
0.0 | 0.0 | GO:0030250 | cyclase activator activity(GO:0010853) guanylate cyclase activator activity(GO:0030250) |
0.0 | 0.1 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
0.0 | 0.1 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.0 | 0.0 | GO:0035514 | DNA demethylase activity(GO:0035514) DNA-N1-methyladenine dioxygenase activity(GO:0043734) |
0.0 | 0.1 | GO:0004046 | aminoacylase activity(GO:0004046) |
0.0 | 0.0 | GO:0004515 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
0.0 | 0.1 | GO:0005546 | phosphatidylinositol-4,5-bisphosphate binding(GO:0005546) |
0.0 | 0.3 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.0 | 0.2 | GO:0005496 | steroid binding(GO:0005496) |
0.0 | 0.1 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.0 | 0.1 | GO:0004331 | fructose-2,6-bisphosphate 2-phosphatase activity(GO:0004331) |
0.0 | 0.1 | GO:0016247 | channel regulator activity(GO:0016247) |
0.0 | 0.0 | GO:0016149 | translation release factor activity, codon specific(GO:0016149) |
0.0 | 0.0 | GO:0005222 | intracellular cAMP activated cation channel activity(GO:0005222) |
0.0 | 0.1 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.0 | 0.1 | GO:0004551 | nucleotide diphosphatase activity(GO:0004551) |
0.0 | 0.0 | GO:0019534 | toxin transporter activity(GO:0019534) |
0.0 | 0.1 | GO:0005537 | mannose binding(GO:0005537) |
0.0 | 0.1 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.6 | 5.5 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.4 | 4.4 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.4 | 11.3 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.3 | 4.9 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.3 | 9.0 | NABA COLLAGENS | Genes encoding collagen proteins |
0.2 | 6.1 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.2 | 0.8 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.2 | 3.8 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.2 | 1.0 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.2 | 6.4 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
0.2 | 27.6 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.2 | 0.3 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.2 | 2.5 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.2 | 1.1 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.2 | 0.8 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.2 | 2.7 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.1 | 1.8 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.1 | 3.4 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.1 | 2.5 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.1 | 0.5 | PID ENDOTHELIN PATHWAY | Endothelins |
0.1 | 2.8 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.1 | 0.2 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.1 | 3.4 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.1 | 1.7 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.1 | 1.5 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.1 | 19.4 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.1 | 0.2 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.1 | 1.6 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.1 | 12.9 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.1 | 0.9 | PID ALK2 PATHWAY | ALK2 signaling events |
0.1 | 21.9 | NABA MATRISOME ASSOCIATED | Ensemble of genes encoding ECM-associated proteins including ECM-affilaited proteins, ECM regulators and secreted factors |
0.1 | 0.1 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
0.1 | 0.2 | PID REELIN PATHWAY | Reelin signaling pathway |
0.1 | 0.1 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.1 | 0.5 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.1 | 0.9 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.1 | 0.2 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.1 | 1.6 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.0 | 0.9 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.0 | 1.4 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.0 | 1.9 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.0 | 0.3 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.0 | 0.8 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.0 | 0.1 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.0 | 0.1 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
0.0 | 0.8 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.0 | 0.1 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.0 | 0.0 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.0 | 0.7 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
0.0 | 0.7 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.0 | 0.1 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.0 | 0.0 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.0 | 0.1 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.0 | 0.1 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.0 | 0.0 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.0 | 0.2 | PID FGF PATHWAY | FGF signaling pathway |
0.0 | 0.2 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 5.3 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.3 | 0.3 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
0.3 | 18.3 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.3 | 4.5 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.3 | 0.3 | REACTOME PLC BETA MEDIATED EVENTS | Genes involved in PLC beta mediated events |
0.3 | 7.2 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.3 | 2.6 | REACTOME ADENYLATE CYCLASE ACTIVATING PATHWAY | Genes involved in Adenylate cyclase activating pathway |
0.3 | 0.3 | REACTOME PI3K EVENTS IN ERBB2 SIGNALING | Genes involved in PI3K events in ERBB2 signaling |
0.2 | 3.6 | REACTOME P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS | Genes involved in p130Cas linkage to MAPK signaling for integrins |
0.2 | 0.2 | REACTOME ACTIVATION OF NMDA RECEPTOR UPON GLUTAMATE BINDING AND POSTSYNAPTIC EVENTS | Genes involved in Activation of NMDA receptor upon glutamate binding and postsynaptic events |
0.2 | 3.6 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.2 | 2.7 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.2 | 4.1 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.2 | 0.9 | REACTOME ARMS MEDIATED ACTIVATION | Genes involved in ARMS-mediated activation |
0.2 | 6.5 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.2 | 1.8 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.2 | 1.9 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.2 | 1.4 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.2 | 2.1 | REACTOME PEPTIDE HORMONE BIOSYNTHESIS | Genes involved in Peptide hormone biosynthesis |
0.1 | 0.4 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.1 | 3.0 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.1 | 3.6 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.1 | 1.0 | REACTOME INCRETIN SYNTHESIS SECRETION AND INACTIVATION | Genes involved in Incretin Synthesis, Secretion, and Inactivation |
0.1 | 1.6 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
0.1 | 1.4 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.1 | 6.1 | REACTOME CELL JUNCTION ORGANIZATION | Genes involved in Cell junction organization |
0.1 | 1.9 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
0.1 | 0.1 | REACTOME OPSINS | Genes involved in Opsins |
0.1 | 1.3 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.1 | 1.4 | REACTOME FGFR2C LIGAND BINDING AND ACTIVATION | Genes involved in FGFR2c ligand binding and activation |
0.1 | 1.9 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.1 | 2.2 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.1 | 1.4 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.1 | 1.8 | REACTOME GRB2 EVENTS IN ERBB2 SIGNALING | Genes involved in GRB2 events in ERBB2 signaling |
0.1 | 1.6 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
0.1 | 0.9 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.1 | 4.6 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.1 | 0.1 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.1 | 0.9 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
0.1 | 1.8 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.1 | 1.4 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
0.1 | 4.3 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.1 | 0.1 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
0.1 | 2.4 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
0.1 | 1.1 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.1 | 1.8 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.1 | 7.4 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.1 | 2.3 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
0.1 | 0.1 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
0.1 | 0.6 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.1 | 0.9 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.1 | 1.0 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
0.1 | 3.7 | REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |
0.1 | 1.4 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.1 | 0.1 | REACTOME FGFR4 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
0.1 | 0.6 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
0.1 | 1.1 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.1 | 0.7 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.1 | 0.7 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.1 | 1.0 | REACTOME FORMATION OF FIBRIN CLOT CLOTTING CASCADE | Genes involved in Formation of Fibrin Clot (Clotting Cascade) |
0.1 | 0.6 | REACTOME NEURONAL SYSTEM | Genes involved in Neuronal System |
0.1 | 0.1 | REACTOME ADP SIGNALLING THROUGH P2RY1 | Genes involved in ADP signalling through P2Y purinoceptor 1 |
0.1 | 0.2 | REACTOME ACTIVATED POINT MUTANTS OF FGFR2 | Genes involved in Activated point mutants of FGFR2 |
0.1 | 0.6 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.1 | 0.3 | REACTOME REGULATION OF INSULIN SECRETION | Genes involved in Regulation of Insulin Secretion |
0.0 | 0.5 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
0.0 | 0.0 | REACTOME CREB PHOSPHORYLATION THROUGH THE ACTIVATION OF CAMKII | Genes involved in CREB phosphorylation through the activation of CaMKII |
0.0 | 0.9 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.0 | 0.0 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 7ALPHA HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol |
0.0 | 0.3 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.0 | 0.3 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
0.0 | 0.2 | REACTOME THROMBOXANE SIGNALLING THROUGH TP RECEPTOR | Genes involved in Thromboxane signalling through TP receptor |
0.0 | 0.8 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
0.0 | 0.4 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
0.0 | 0.4 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.0 | 0.4 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.0 | 0.0 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS | Genes involved in Synthesis of bile acids and bile salts |
0.0 | 0.4 | REACTOME KERATAN SULFATE KERATIN METABOLISM | Genes involved in Keratan sulfate/keratin metabolism |
0.0 | 0.3 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.0 | 0.2 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
0.0 | 0.7 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.0 | 0.4 | REACTOME INITIAL TRIGGERING OF COMPLEMENT | Genes involved in Initial triggering of complement |
0.0 | 0.3 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |
0.0 | 0.4 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
0.0 | 0.3 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.0 | 0.1 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.0 | 4.3 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.0 | 0.4 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.0 | 0.2 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
0.0 | 1.2 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
0.0 | 0.3 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.0 | 0.0 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
0.0 | 0.5 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.0 | 0.0 | REACTOME REGULATION OF GLUCOKINASE BY GLUCOKINASE REGULATORY PROTEIN | Genes involved in Regulation of Glucokinase by Glucokinase Regulatory Protein |
0.0 | 0.1 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.0 | 0.3 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.0 | 0.1 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.0 | 0.1 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
0.0 | 0.2 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.0 | 0.3 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
0.0 | 0.3 | REACTOME ACYL CHAIN REMODELLING OF PC | Genes involved in Acyl chain remodelling of PC |
0.0 | 0.1 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
0.0 | 0.0 | REACTOME REGULATION OF APOPTOSIS | Genes involved in Regulation of Apoptosis |
0.0 | 0.3 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.0 | 0.4 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.0 | 0.1 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
0.0 | 0.2 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.0 | 0.5 | REACTOME SIGNALING BY PDGF | Genes involved in Signaling by PDGF |